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ABSTRACT OF DISSERTATION

DEVELOPMENT OF TOOLS FOR ATOM-LEVEL INTERPRETATION OF STABLE
ISOTOPE-RESOLVED METABOLOMICS DATASETS
Metabolomics is the global study of small molecules in living systems under a given
state, merging as a new ‘omics’ study in systems biology. It has shown great promise in
elucidating biological mechanism in various areas. Many diseases, especially cancers, are
closely linked to reprogrammed metabolism. As the end point of biological processes,
metabolic profiles are more representative of the biological phenotype compared to
genomic or proteomic profiles. Therefore, characterizing metabolic phenotype of various
diseases will help clarify the metabolic mechanisms and promote the development of novel
and effective treatment strategies.
Advances in analytical technologies such as nuclear magnetic resonance and mass
spectroscopy greatly contribute to the detection and characterization of global metabolites
in a biological system. Furthermore, application of these analytical tools to stable isotope
resolved metabolomics experiments can generate large-scale high-quality metabolomics
data containing isotopic flow through cellular metabolism. However, the lack of the
corresponding computational analysis tools hinders the characterization of metabolic
phenotypes and the downstream applications.
Both detailed metabolic modeling and quantitative analysis are required for proper
interpretation of these complex metabolomics data. For metabolic modeling, currently
there is no comprehensive metabolic network at an atom-resolved level that can be used
for deriving context-specific metabolic models for SIRM metabolomics datasets. For
quantitative analysis, most available tools conduct metabolic flux analysis based on a welldefined metabolic model, which is hard to achieve for complex biological system due to
the limitations in our knowledge.
Here, we developed a set of methods to address these problems. First, we developed
a neighborhood-specific coloring method that can create identifier for each atom in a
specific compound. With the atom identifiers, we successfully harmonized compounds and
reactions across KEGG and MetaCyc databases at various levels. In addition, we evaluated
the atom mappings of the harmonized metabolic reactions. These results will contribute to
the construction of a comprehensive atom-resolved metabolic network. In addition, this
method can be easily applied to any metabolic database that provides a molfile
representation of compounds, which will greatly facilitate future expansion. In addition,
we developed a moiety modeling framework to deconvolute metabolite isotopologue
profiles using moiety models along with the analysis and selection of the best moiety
model(s) based on the experimental data. To our knowledge, this is the first method that
can analyze datasets involving multiple isotope tracers. Furthermore, instead of a single
predefined metabolic model, this method allows the comparison of multiple metabolic
models derived from a given metabolic profile, and we have demonstrated the robust
performance of the moiety modeling framework in model selection with a 13C-labeled
UDP-GlcNAc isotopologue dataset. We further explored the data quality requirements and

the factors that affect model selection. Collectively, these methods and tools help interpret
SIRM metabolomics datasets from metabolic modeling to quantitative analysis.
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Isomorphism, Metabolic Database Harmonization, Atom Identifier
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CHAPTER 1. BACKGROUND
1.1

Metabolomics
Metabolomics can be generally defined as the comprehensive study of small-

molecule metabolites (<1500 Da) in a biological system (cell, tissue or organism) in a given
state[1]. It is marked as the new ‘omics’, joining genomics, transcriptomics, and
proteomics to achieve a better understanding of global systems biology[2]. Metabolites
represent a wide range of molecules, such as lipids, amino acids, nucleic acids, vitamins
and carbohydrates, playing various functions in biological systems, including energy
production, macromolecules synthesis, and pathway signaling[3]. The quantitative
collection of all metabolites present in a cell or organism involved in metabolic reactions
is called the metabolome[4]. Compared to other ‘omics’ studies, metabolomics has a
number of unique advantages[5]. First, metabolites are considered to be the molecular
endpoint of many biological processes and an important molecular midpoint of most other
biological processes. As the downstream of transcriptome and proteome, the metabolome
can reflect the functional level of a cell more appropriately[6], suggesting metabolic
profiles are more proximal to a biological phenotype than either genetic or proteomic
profiles. Also, changes in the metabolome are supposed to be magnified relative to
proteome or transcriptome. Additionally, the metabolic profiles are combinational results
of gene expression and environmental stresses[7]. Therefore, metabolomics can provide
great insights into the interaction of a biological system with its living environment.

It is becoming increasingly clear that metabolomics research can help open up
many previously inaccessible biological fields, including health, disease, nutrition,
environment and agriculture[8, 9]. One important area affected by metabolomics is
1

prokaryotic genome annotation. At least 30%-50% of genes in a bacterial genome are
hardly or incorrectly annotated[10], and the function of 20% genes in the best understood
bacteria genome is actually unknown[11]. Small molecule signatures would allow
functional hypotheses and/or determination of those unknown genes. In addition, system
wide analysis and understanding of metabolic processes have proven valuable in devising
strategies of metabolic engineering for microorganisms[12]. More importantly,
metabolomic studies can help with the identification of biomarkers for metabolic-related
diseases[13] as well as the discovery and development of therapeutic agents[14, 15]. This
will be discussed in more details in the next section.

1.2

Metabolic Reprogramming
Metabolic reprogramming is a critical feature in cancer and many other diseases. It

has been recognized as one of the 10 hallmarks of cancer[16]. Back to 100 years ago, Dr.
Warburg discovered that certain cancer cells predominantly produce energy through the
glycolytic pathway rather than via the tricarboxylic acid (TCA) cycle even under normoxic
conditions[17]. Despite the exact roles of metabolic reprogramming in cancers remaining
unclear, advances in cancer metabolism research over the past decade have improved our
understanding of how aerobic glycolysis and other metabolic alterations support the growth,
proliferation and metastasis needs of cancer cells[18].
For example, glycolysis not only provides cancer cells with energy but also necessary
precursors for biosynthesis (lipids, proteins, and carbohydrates). Several glycolytic
metabolites, like glucose-6-phosphate, dihydroxyacetone phosphate, also take part in other
metabolic pathways. Glucose-6-phosphate can be consumed by pentose phosphate

2

pathway to synthesize nucleotides. Dihydroxyacetone phosphate can be involved in lipid
production[19].
Apart from glycolysis, many cancer cells also rely on glutaminolysis for cellular
bioenergetics. Glutaminolysis is composed of a set of reactions converting glutamine into
glutamate, α-ketoglutarate, etc. These products are indispensable for TCA cycles in the
cancer cells, and the intermediates of TCA cycles are the building blocks of lipids, amino
acids and other important metabolites[20, 21].
Increased lipid metabolism is another critical feature of cancer metabolism. Several
enzymes, such as ATP citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), and fatty
acid synthase (FASN), are involved in the multi-step lipid biosynthesis. Cancer cells need
enhanced de novo fatty acid biosynthesis to meet their increased demands for lipids[22-24]
FASN is upregulated in breast, prostate and other types of cancers[25-27]. In addition,
cancer cells often have higher lipid accumulation as lipid droplets compared to normal
cells[28].
In addition, upregulation of mitochondrial biogenesis, pentose phosphate pathway as
well as other biosynthetic and bioenergetic pathways is also observed in certain cancer
cells. The altered metabolism provides cancer cells with necessary energy as well as crucial
materials to support rapid proliferation, survival, and invasion. Given the indispensable
role of reprogrammed metabolism for cancers, it is promising to develop anti-cancer
therapies targeting cancer bioenergetics. A lot of compounds have been studied and tested
to selectively and effectively suppress metabolic enzymes that are essential to cancer cells.
One of the most popular anti-cancer metabolism therapeutic strategies is to inhibit
enzymes that are most or even exclusively expressed in cancer cell, which will effectively

3

kill tumors while causing little harm to normal cells. Inhibitors for Glutaminase 1 (GLS1),
a glutaminase isoform that is highly upregulated in cancer cells, have proved to be effective
in cancer treatment by blocking GLS1[29, 30]. Glycolysis inhibitors are also of great
interest to many groups of researchers. For example, 2-deoxyglucose (2-DG) can block
glycolysis by reversely inhibiting hexokinase, which is among the most advanced cancer
metabolism inhibitors in clinical trials[31-33].
Furthermore, metabolism therapies can be combined with other therapies to achieve
better efficacy. Metabolic adaptation is often involved in the resistance to cancer
treatment[34]. For instance, increased glycolysis has been associated with the resistance of
breast cancer cells to HER-2-targeting trastuzumab. Synergistical combination of
trastuzumab with glycolysis inhibitors have proven to be effective in trastuzumab-sensitive
and trastuzumab-resistant breast cancers both in vitro and in vivo[35].
Recent remarkable advances in metabolic reprogramming have inspired exciting
research in the development of anti-cancer metabolism therapies, which is expected to play
important roles in the future clinical oncology. Large-scale characterization of metabolic
phenotypes for various cancers will further help clarify the mechanisms of metabolic
disease and promote the development of novel and effective treatment strategies.

1.3

Metabolic Network and Metabolic Model
Metabolomics data represents complex interaction among metabolites on a global

scale rather than a collective of individual components[36]. Therefore, analyzing data from
a network perspective is more likely to capture meaningful information that can be missed
via differential analysis of individual metabolites. At an abstract but computationally useful
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level, metabolic network can be represented as mathematical graphs, where each node is a
specific metabolite and the edges describe the biotransformation pathways[37]. The
representation of metabolic network as graph allows systematical investigation of the
biological system via well-understood graph theoretical concepts and algorithms.
Therefore, a high-quality reconstruction of metabolic network is of great interest to the
community of scientific researchers working in the systems biology of metabolism.
Huge efforts have been devoted to the reconstruction, such as Recon 1[38], the
Edinburgh Human Metabolic Network (EHMN)[39], and Recon 2[40]. These are genomescale metabolic networks constructed by combining various sources of ‘omics’ and
literature data. However, due to the limitations in our knowledge of the complexity of
human genome, current reconstructions of the global metabolic network are not complete.
For example, only about 1000 genes that are common to human Recon 1 and EHMN[41],
promoting to the reconstruction of Recon 2 by harmonizing metabolic information in four
different resources (EHMN[39], HepatoNet1[42], Ac-FAO module[43] and the human
small intestinal enterocyte reconstruction[44]) to Recon 1[40]. In total, 7440 reactions and
2626 unique metabolites are collected in the Recon 2. Even though EHMN, Recon, and
Recon 2 are limited to human metabolism, compared to the KEGG (11427 reactions and
18636 metabolites) and MetaCyc (17203 reactions and 20264 metabolites) repositories
which cover known metabolism of many organisms, it can be seen that the reconstruction
of comprehensive metabolic network still has a long way to go. However, efficient
integration of metabolic data across different databases remains a big challenge. Nonuniform compound identifiers and reaction names are two main blocks for the integration.
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Clearly, many reactions in a genome-scale metabolic network are not active under a
particular condition[45]. When it comes to analysis and interpretation of a specific
metabolic profile, an essential step is to derive a predictive metabolic model for the
corresponding context based on the global metabolic network. Such context-specific
metabolic models are proven to exhibit better explanatory power and predictive
performance than generic models[46, 47]. On the other hand, a comprehensive metabolic
network is the premise for deriving context-specific metabolic models with high biological
interpretability.

1.4

Stable Isotope Resolved Metabolomics
Since a metabolite can participate in many interweaved reactions, especially for some

hot spots like glutamate, it is practically impossible to discern the contributions of each
pathway segment only based on the metabolome[48]. To overcome this issue, isotopic
tracers (2H,

13C, 14C, 15N

and others) can applied in the metabolic studies, where an

isotopically enriched precursor is applied to a biological system such that its metabolic
transformations can be traced via the labeled atoms[49, 50]. 13C is the most frequently used
stable isotope in cancer metabolism research. A lot of 13C-enriched precursors, like several
isotopomers of D-glucose, are commercially available. Double element isotope-labeled
metabolites like [U-13C,15N]-glutamine are also common. The wide variety of stable
isotope-labeled sources greatly facilitate the experimental design for raveling the intricate
metabolic segments.
The typical stable isotope resolved metabolomics (SIRM) pipelines are shown in
Figure 1.1[48]. Stable isotope tracers such as 13C-labeled glucose are first administrated to
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the experimental targets via addition to the culture medium or through injection into the
whole organism. The absorbed tracers will be used for synthesizing new metabolites. After
certain period of incubation, the isotopically enriched metabolites will be extracted for
quantification.

Figure 1.1. Stable isotope-resolved metabolomics (SIRM) pipelines.
Two chemical analytical features are derived from the incorporation of stable
isotopes: isotopologues and isotopomers. Isotopologues are molecules that differ only in
their isotopic composition[51]. Isotopomers are molecules having the same number of each
isotope of each element but differing in their positions. Using alanine as an example (Figure
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1.2), incorporation of

13C

can generate 4 sets of distinct isotopologues and 8 distinct

isotopomers.

Isotopomers
12C-Ala

13C

1-Ala

Isotopologues
13C

2-Ala

13C

3-Ala

O
NH2

O
NH2

O
NH2

O
NH2

O
NH2

O
NH2

O
NH2

O
NH2

Figure 1.2. Isotopologues and isotopomers.
Nuclear magnetic resonance (NMR) and mass spectroscopy (MS) are quintessential
analytical tools for metabolite detection and characterization. While NMR is extremely
powerful for elucidating organic structures at the atom position-specific level (i.e.
isotopomer), it is disadvantaged by its poor sensitivity. Only metabolites present in
relatively high concentrations can be reliably detected and quantified by NMR[1]. MS can
measure isotopologue-specific data with higher sensitivity; however, an isotopologue
represents a set of mass-equivalent isotopomers.
When MS and NMR are applied in SIRM experiments, detailed sub-metabolite
features representing isotopic flux through cellular metabolism can be detected on
potentially thousands of metabolites in a biological system. However, it also brings another
big challenge of how to properly interpret the sophisticated data.
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1.5

Metabolic Flux Analysis
Merely detecting all the metabolites in a biological system cannot directly reveal the

most biologically and dynamically relevant aspect of metabolism, metabolic fluxes (i.e. the
flow of materials through metabolism) [52]. For example, we can hardly know what lead
to the accumulation or depletion of the target metabolites just based on their concentration.
Quantitative and qualitative knowledge of metabolic fluxes over a metabolic model can
help understand the contribution of each pathway segment, which provide insights into the
regulation of metabolism[53, 54]. The metabolic flux analysis (MFA) can be defined as a
collective set of techniques to derive the rates of metabolic reactions [55]. Initially, MFA
depended solely on balancing fluxes around metabolites in the predefined metabolic model.
As we discussed above, the stoichiometric constraints cannot provide enough information
to calculate the fluxes of interest, especially for complex systems. Therefore, we
incorporate stable isotopes into the biological system so that metabolites with distinct
isotope-specific patterns can be produced. The isotope measurements provide plenty of
additional independent constraints for MFA[56].
Several software packages have been developed to facilitate flux analysis. Earlier
metabolic flux analysis focused on local fluxes[57-62]. To serve this purpose, only a small
subset of metabolic features was used to calculate the predefined analytic formulas. This
type of approaches is mathematically simple and rapid with significant limitations. Since
these formulas are derived with strong intuition and tacit assumptions, only a dozen can be
applied to interpret the central metabolism of microbes with single carbon tracer. Recently,
more efforts have been devoted to achieving systematic metabolic fluxes analysis in an
iterative fitting manner [55, 56, 63-66]. All the measured metabolic features are used to
9

estimate metabolic fluxes across the entire system. In this case, the fitting process of
metabolic flux to detected metabolic data can be mathematically cumbersome. For
complex system, it can take extensive computational time. Furthermore, this approach is
not quite suitable for high-throughput analyses since it requires quantification of each
sample individually. In addition, for complex metabolomics dataset, expert knowledge is
required for quality control. The final results heavily depend on the correctness of the
metabolic model, the assumptions made, as well as the precision of detected data.
Some machine learning algorithms also have been implemented for analyzing flux
ratios based on
measured

13C

13C-labeled

data[67]. In the SUMOFLUX machine learning model, the

isotope labeling patterns of the metabolites are the input features and the

metabolic fluxes are the dependent variables to predict. Simulated data that fulfills the
stoichiometric constraints of the metabolic network was generated to train the random
forest model. Once the random forest predictor is constructed, it will be very efficient in
estimating the metabolic fluxes for real data.
The methods mentioned above do facilitate the interpretation of complex
metabolomics datasets. However, they also show some obvious limitations. First, they all
highly depend on a predefined metabolic model, which is feasible for well-understood
metabolism. For complex biological systems especially for non-model organisms, the
metabolic model is far from complete. In addition, these tools can only deal with 13C-data,
which limits most of the current isotope tracer experiments to 13C tracer. In Chapter 4, we
developed the moiety modeling framework to address these problems.
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1.6

Challenges in Interpreting SIRM Derived Metabolome
To better decipher the complex metabolomics data, both detailed modeling and

quantitative analysis are required. As we discussed above, a comprehensive metabolic
network is the premise for deriving context-specific metabolic models. In a traditional
metabolic network, each node is a specific metabolite, where information at atom level is
not representative. Here, we can see that the gap of descriptions between metabolic network
(metabolite level) and SIRM metabolic profiles (atom level). In this case, metabolic
features containing isotopic details derived from SIRM experiments cannot be fully utilized
in the construction of context-specific metabolic models. To bridge this gap, we need a
metabolic network at atom level, where each node represents an atom from a specific
metabolite rather than the whole metabolite. However, currently there are no relatively
complete atom-resolved databases of metabolic networks available for human metabolism.
In addition, we have discussed that it is difficult to construct a well-defined
metabolic model for a complex system given our current level of knowledge of metabolism,
particularly at the atom-resolved level. Since the current metabolic network is far from
complete, multiple plausible metabolic models can be derived for a specific metabolic
profile based on partial information. This causes another problem of model selection.
However, this issue has not been fully studied yet. Here, we can see that issues exist in
metabolic modeling for SIRM datasets at various stages.
The metabolic model is the cornerstone for downstream quantitative analysis. Our
preliminary analysis indicated that a metabolomics dataset can have dramatically distinct
metabolic fluxes interpretation under different metabolic models. Therefore, rigorous
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method should be developed to facilitate initial model construction and ensure optimal
model selection.

1.7

Overview of Dissertation
Even though a large volume of high-quality metabolomics data has been generated

recently, there is still a lack of computational tools and methods for analyzing and
interpreting those data, especially for metabolomics datasets derived from SIRM
experiments. The overall goal for this dissertation is to develop computational tools and
methods for analyzing and interpreting metabolomics data at the atom-resolved level. Here,
we focused on two major parts, construction of a relatively complete atom-resolved
metabolic network and development of moiety model framework for SIRM datasets.
To construct an atom-resolved metabolic network, the very first step is to distinguish
every node (i.e. an atom from a specific metabolite) in the network. In Chapter 2, we
developed a neighborhood-specific coloring method for creating atom identifiers in a
specific compound. In addition, compound identifiers derived from atom identifiers can be
used for compound harmonization across various metabolic databases. Furthermore, we
achieved hierarchical integration of metabolic reactions in KEGG and MetaCyc via an
iterative combination of compound and reaction harmonization steps in Chapter 3.
After constructing an atom-resolved network, the next step is to derive metabolic
models based on the metabolic profile and metabolic network and achieve metabolic flux
analysis. In Chapter 4, we described a moiety modeling framework for deconvoluting
SIRM isotopologue datasets. Usually, multiple models can be derived from a specific
metabolic profile. This method helps with the selection of optimal model for the
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downstream analysis. In Chapter 5, we further analyzed how various factors (optimization
method, optimizing degree, objective function and selection criterion) affect model
selection.
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CHAPTER 2. NEIGHBORHOOD-SPECIFIC COLORING METHOD FOR CREATING ATOM
IDENTIFIER IN A COMPOUND

2.1

Introduction
Metabolic flux analysis is an essential approach to access metabolic phenotypes[53,

65] that requires both reliable metabolic profiles as well as reliable metabolic models[6870]. Advances in analytical technologies like mass spectrometry (MS) and nuclear
magnetic resonance (NMR) greatly contribute to the detection of thousands of metabolites
from biofluids, cells, and tissues[71]. Application of those analytical techniques to stable
isotope resolved metabolomics (SIRM) experiments facilitates production of high-quality
metabolomics datasets capturing isotopic flux through cellular and systemic
metabolism[48, 72]. Now, the challenge is to construct meaningful metabolic models from
the corresponding metabolic profiles for downstream metabolic flux analysis. A metabolic
network is usually represented by compounds connected via biotransformation routes[37].
Obviously, information at the atom level is not represented in such metabolic networks,
making it impractical to derive appropriate metabolic models for SIRM datasets. Prior
work demonstrated an atom-resolved metabolic network that included both central and
intermediate metabolism in Escherichia coli that allowed atom-to-atom tracing[73, 74].
However, currently there are no relatively complete atom-resolved databases of metabolic
networks available for human metabolism that can be used to trace individual atoms[72].
To construct an atom-resolved metabolic network, compounds and metabolic
reactions with detailed documentation at the atom level are required. One approach is to
reconstruct a hypothetical atom-resolved metabolic network from generalized reaction
descriptions that are atom-specific[75]. However, it is unclear the level of validation and

curation that such an approach would require to construct a reasonably accurate atomresolved metabolic network for generating metabolic models usable in the analysis of
SIRM datasets. An alternative is to use curated metabolic databases currently available, in
particular the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the MetaCyc
metabolic pathway database. The popular molfile description of a compound is a text-based
chemical table file format developed by MDL Information Systems and contains
information about atoms, bonds, connectivity, and coordinates[76], which is available in
most databases including KEGG and MetaCyc. For atom-resolved metabolic reactions, the
KEGG reaction pair (RPAIR) database stores patterns of transformations occurring
between two reactants in a single reaction[77]. In addition, MetaCyc contains direct atom
mappings for every metabolic reaction[78]. Previous work only made use of atom
mappings in either the KEGG RPAIR database[79, 80] or MetaCyc[81] for atom tracing.
However, both databases cover metabolism for many common organisms, clearly
indicating that these two databases are not independent of each other. A necessary first step
for constructing a more comprehensive network is to integrate compounds from different
databases without redundancy[82].
In an atom-resolved metabolic network, each node should include information at
both molecule-specific and atom-specific levels. To name each atom in a compound, two
rules need to be obeyed: 1) different atoms must have different identifiers; 2) and
symmetric atoms must share the same identifier. Previous work used the atom index in the
molfile associated with a compound in finding atom-specific metabolic pathways without
considering molecular symmetry[80, 81]. Likewise, molecular symmetry has been ignored
in prior atom-resolved metabolic network reconstruction approaches[75]. One group tried
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to assign a unique name for every atom in the compound based on the compound’s
International Union of Pure and Applied Chemistry (IUPAC) International Chemical
Identifier (InChI) representation[83], which does not apply to this scenario since symmetric
atoms can share the same routes in the metabolic network. Also, any InChI-based approach
cannot handle the compound entries with R-groups. To our knowledge, no appropriate
method has been previously published that provides each atom in a compound with a useful
identifier for the explicit purpose of constructing an atom-resolved metabolic network,
either because the identifier was not unique or because it was not consistent for symmetric
atoms.
Here, we developed a novel neighborhood-specific graph coloring method that
creates a unique identifier for each atom in a compound by expanding the type (color) of
each atom based on its “neighborhood” of atoms (nodes) bonded (edges) to it. This
approach is related to but distinct from atom typing performed in chemoinformatics, which
determines an augmented atom type based on the local chemical environment, especially
the directed bonded atoms[84]. Atom coloring creates an augmented atom type based on
both directly and indirectly bonded atoms that are part of the graph neighborhood around
a given atom. Moreover, the method is guaranteed to generate the same coloring identifier
for symmetric atoms. Furthermore, compound coloring identifiers derived from the
corresponding atom coloring identifiers can be used for compound harmonization across
metabolic databases. In this context, only molecular configuration (i.e. changes requiring
the breaking of a bond) and not molecular conformation (i.e. changes not requiring the
breaking of a bond like a bond rotation) are considered in the generation of these identifiers.
To our knowledge, this is the first attempt to create unique atom and compound identifiers
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that are consistent with respect to molecular symmetry and for the explicit purpose of
harmonizing compounds across the KEGG and MetaCyc databases, ultimately to facilitate
the construction of an integrated atom-resolved metabolic network.

2.2
2.2.1

Materials and Methods
Compound and metabolic reaction data
All data were downloaded directly from the corresponding databases. The KEGG

COMPOUND and KEGG REACTION data is from the version available from KEGG on
May 2019 via its REST interface. MetaCyc compound and reaction data is in version 23.0,
downloaded from BioCyc.
2.2.2

Overview of major analysis steps
A compound can be represented as a graph where each node is an atom in the

compound and each edge between atoms is a chemical bond. Based on the molfile, we are
able to create a graph representation for the corresponding compound. After we detect the
aromatic substructures for a compound, we can change the bonds within the aromatic
substructures to aromatic type (molfile[76] bond designation 4). After curation of aromatic
substructures and double bond stereochemistry, we performed atom coloring and
validation to guarantee that symmetric atoms share the same identifier and different atoms
have different identifiers. Each set of atom identifers for a compound is used to derive the
corresponding compound coloring identifier. Finally, we detect corresponded pairs of
compounds across two databases using ordered compound identifiers for each compound
in each database. The flowchart of the overall compound harmonization procedure is
shown in Figure 2.1.
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Parse molfile representation

Detect aromatic substructure

Identify double bond stereochemistry

Color atoms and validate

Generate ordered compound identifiers

Detect corresponded compound pairs

Figure 2.1. Overview of major compound harmonization steps.
2.2.3

Molfile parser
We used a modified ctfile Python 3 package[85] to parse a molfile into atom and

bond blocks, and save them into the JavaScript Object Notation (JSON) format[86],
facilitating access and modification.
2.2.4

Aromatic substructure detection
We used two methods in aromatic substructure detection. One is based on common

subgraph isomorphism detection, and the other is an automatic aromatic atom detection
method in Indigo packages[87]. In the KEGG database, aromatic atoms in a compound are
specified in its KEGG Chemical Function (KCF) file[88]. Based on the aromatic atoms,
we were able to extract the aromatic substructures present within a compound, and then
saved every substructure into a separate molfile. If several aromatic rings are connected,
we would fuse them together as one substructure. Then, we built a set of all aromatic
substructures detected from the KEGG compounds without duplication. Furthermore, we
manually inspected the set of aromatic substructures to ensure data quality. With this
18

curated set of reference aromatic substructures, we tested each compound in a database for
the presence of any of these aromatic substructures using the BASS method[89]. We
analyzed KEGG to validate the aromatic substructure detection method itself. Then, we
analyzed MetaCyc and labeled the bonds of detected aromatic substructures as aromatic.
Furthermore, valid aromatic substructures in MetaCyc compounds can be detected by
Indigo and other IDs. Finally, we created 366 KEGG-derived and 21 MetaCyc-derived
aromatic substructures in the reference aromatic substructure set.
2.2.5

Identification of double bond stereochemistry
The C=C double bond stereochemistry is not clearly specified in the molfile in both

databases. To distinguish cis/trans stereoisomers, we adopted a method for automated
identification of double bond stereochemistry[90]. This method requires fully
hydrogenated compounds. Therefore, we first used Open Babel[91] to add hydrogen atoms
for every compound, and then performed the calculation.
2.2.6

Neighborhood-specific graph coloring method
Our neighborhood-specific graph coloring method is based on a breadth first search

algorithm[92]. This method names each atom based on its own and neighbors’ chemical
information, which can include atom type, atom charge, atom stereochemistry, isotope,
bond type, and bond stereochemistry. The method is flexible in adjusting the chemical
information included in the atom coloring. A flowchart of the graph coloring method is
shown in Figure 2.2. First, the method named each atom with its own chemical information,
which will be saved as the 0_layer identifier and the start of the current atom identifier.
Then, the method builds a dictionary that relates each atom with its 0_layer identifier and
directly linked atoms. Directly bonded atoms of each atom are initialized as its neighbors.
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The method continues to extend the name of each atom, adding information about its
neighbors into the 0_layer dictionary to its current identifier, and updating neighbors with
neighbors’ neighbors that have not been used in extending the name of that atom. The
method first repeats this process 3 times for all the atoms to avoid early stopping that can
lead to non-unique compound coloring identifiers. Then, the method checks if an atom has
a unique identifier. Atom naming will continue for those atoms that still share the same
identifiers with other atoms until all the atoms in the compound have been used in name
extension. Finally, the current name for each atom will be its coloring identifier. Compound
C00047 in the KEGG database (Figure 2.3) is used as an example to illustrate how the
method works (Table 2.1).
Name each atom with its own chemical information (0_layer & current identifier).

Create a 0_layer dictionary of each atom with its own
plus directly linked atoms’ 0_layer identifiers.

Initialize each atom’s neighbors with its directly linked atoms.

Extend an atom’s current identifier with its neighbors’ information into
the 0_layer dictionary, and update its neighbors with neighbors’
neighbors that have not been used in name extension for that atom.

Continue the above process if an atom does not
have a unique current identifier.

Figure 2.2. Flow chart of atom coloring.
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If an atom has a unique current identifier
OR all the atoms in the compound has been
used in name extension. STOP

7

9
10

8

5

2

1
3
6
4

Figure 2.3. KEGG Compound C00047.
Table 2.1. Generation of atom identifiers for compound C00047 via graph coloring method.
Round
Atom identifier
Atom index
1

2

3

C

1, 2, 3, 5, 8, 9

N

4, 10

C

6, 7

C(C(C,1)(C,1)(N,1))

1

C(C(C,1)(C,1))

2, 5, 8

C(C(C,1)(O,1)(O,2))

3

N(N(C,1))

4, 10

O(O(C,1))

6

O(O(C,2)

7

C(C(C,1)(N,1))

9

C(C(C,1)(C,1)(N,1))(C(C,1)(C,1)C(C,1)(O,1)(O,2)N(C,1))

1

C(C(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)(N,1))

2

C(C(C,1)(O,1)(O,2))(C(C,1)(C,1)(N,1)O(C,1)O(C,2))

3

N(N(C,1))(C(C,1)(C,1)(N,1))

4

C(C(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1))

5

O(O(C,1))(C(C,1)(O,1)(O,2))

6

O(O(C,2))(C(C,1)(O,1)(O,2))

7

C(C(C,1)(C,1))(C(C,1)(C,1)C(C,1)(N,1))

8

C(C(C,1)(N,1))(C(C,1)(C,1)N(C,1))

9

N(N(C,1))(C(C,1)(N,1))

10

Only chemical information of atom type and bond type is included in atom naming. The first three rounds of naming are
shown above.

2.2.7

Atom coloring validation and recolor
The atom coloring validation and recoloring are also based on a breadth first search

algorithm. The atom coloring validation flowchart is shown in Figure 2.4. For atoms with
the same coloring identifier, we checked if neighbors of these atoms are also the same,
layer by layer, until all the atoms in the compound have been tested. Then, the recoloring
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method will correct atoms with the same identifier that don’t have the same neighbors. The
recoloring process is similar to the graph coloring method. Instead of creating a 0_layer
identifier dictionary, we will use a full identifier dictionary. In addition, we only color
atoms to where they have different neighbors to distinguish between them.
Atoms in a compound share the same identifier.

Create a full identifier dictionary of each atom
with its own plus neighbors’ identifier.

Initialize each atom’s neighbors with its directly linked atoms.

Check if the neighbors’ information in the dictionary is also the same for
atoms with the same identifier, and update atoms’ neighbors with
neighbors’ neighbors that have not been used in validation for that atom.

If neighbors are the same, continue the above
process until all the atoms in the compound
have been used in validation for that atom.

If neighbors are different, recolor these
atoms till this layer.

Figure 2.4. Flow chart of atom coloring.
2.2.8

Creation of compound coloring identifiers based on atom coloring identifiers
Once we create the identifiers for all the atoms in a compound, we can combine the

number of atoms with the same identifier along with the atom coloring identifier. We sorted
all the substrings, and then concatenated them together to form an ordered coloring
identifier for the compound. The formulation is shown in Equation 1, which represents the
order of string concatenation with nk being the number of atoms with coloring ak. The
parenthesis and bracket characters are included in the resulting string.
𝐶𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑐𝑜𝑙𝑜𝑟 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑟 = (𝑛1 )[𝑎1](𝑛2 )[𝑎2](𝑛3)[𝑎3] … . (𝑛𝑘 )[𝑎𝑘 ]
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(1)

2.2.9

Prediction of possible compound correspondence via metabolic reactions
We connected each compound with the metabolic reactions it is a part of. For

matched compounds between KEGG and MetaCyc, we tested if the compound shares at
least one metabolic reaction indicated by the EC number in both databases.

2.3
2.3.1

Results
Overview of KEGG and MetaCyc databases
The numbers of compounds and atom-resolved reactions in KEGG and MetaCyc

databases are summarized in Table 2.2. MetaCyc has 1.09 times as many compound entries
as KEGG and 1.53 times as many atom-resolved reaction entries.
Table 2.2. KEGG and MetaCyc databases
Data types
KEGG
Compounds
18636
Reactions
11427
Atom-resolved reactions
10282
aRatio

MetaCyc
20264
17203
15909

aMetaCyc/KEGG

1.09
1.51
1.53

of MetaCyc entries to KEGG entries

To initially evaluate the level of overlap between KEGG and MetaCyc databases,
we used existing identifiers in each database to find the correspondences between KEGG
and MetaCyc compounds. Not all compounds in either database have all the chemical
identifiers listed in Table 2.3. Some compounds in MetaCyc have a direct identifier to the
corresponding KEGG compound[81]. We can see that the number of matched compounds
(correspondences) detected by different identifiers are not consistent, with the total less
than 5700. We also generated InChI identifiers based on the molfile provided for each entry
in each database using Open Babel[91], which utilizes the InChI software library provided
by the InChI Trust[93]. We were able to generate 16530 InChI from KEGG and 15765
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InChI from MetaCyc, providing 3103 correspondences. When combined with ChEBI and
KEGG Compound IDs, a total of 5929 consistent correspondences were detected. Two
issues may appear when applying these identifiers to compound integration across various
databases. On the one hand, there is no easy way to check if some correspondences are
missing. Besides, it is difficult to tell if the results generated by those identifiers are correct,
since errors can exist in every database[83, 94]. Such errors are illustrated by the 964 out
of 13216 KEGG compound entries with InChI that are inconsistent with the InChI
generated from their associated molfile, representing 7.3% of the InChI-containing entries
in KEGG. Likewise, 55 out of 15076 MetaCyc compound entries have InChI that are
inconsistent with the InChI generated from their associated molfile, representing 0.4% of
the InChI-containing entries in MetaCyc.
Table 2.3. Correspondences between KEGG and MetaCyc compounds
Identifiers
KEGG
MetaCyc
Correspondences
InChI
13216 (70.9%)
15076 (74.4%)
2336
ChEBI
15353 (82.4%)
8404 (41.5%)
3106
KEGG
18636 (100%)
5402 (26.7%)
5402
Either-ID
18636 (100%)
15216 (75.1%)
5681
InChI: IUPAC International Chemical Identifier.
ChEBI: Chemical Entities of Biological Interest.

Therefore, a reliable systematic naming method for chemical compounds that
solves problems at the atom-level as well as the compound-level is required for
constructing an atom-resolved metabolic network. Towards this end, we have developed a
neighborhood-specific graph coloring method that derives unique identifiers for atoms as
well as compounds.
2.3.2

Aromatic substructure detection
The neighborhood-specific graph coloring method is very sensitive to the specific

structural representation. Moreover, aromatic substructures are not consistently
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represented in both databases. Instead of being directly labeled as an aromatic bond type,
single and double bonds are used alternatively to depict the aromatic substructure. CPD6962 in MetaCyc has a direct reference KEGG compound C15523 (Figure 2.5). We can
see that the positions of double bonds and single bonds within the benzene ring vary
between these two representations, which can lead to two different sets of atom identifiers.
Therefore, we needed to ensure that compound representation is consistent across
databases so that each compound will have a single set of atom identifiers. In this case, we
first detect the aromatic substructures in all compounds from both databases, and change
the single and double bonds within the aromatic substructure to aromatic bond.

KEGG: C15523

MetaCyc: CPD-6962

Figure 2.5. Correspondence between KEGG and MetaCyc compound entries with different
molecular representations.
Two independent aromatic detection methods were used in aromatic substructure
detection: our Biochemically Aware Substructure Search (BASS) method[89] which uses
neighborhood-specific graph coloring[95] to greatly improve subgraph isomorphism
detection[96] and the aromatic detection facilities in the Indigo package[87]. First, we
compared the aromatic substructures derived by these two methods. As shown in Table 2.4,
Indigo appears more conservative than BASS in detecting aromatic substructures,
detecting roughly 85% of what the BASS method does. Figure 2.6 shows an example
aromatic substructure that can be missed by Indigo. We assume that Indigo cannot detect
aromatic substructures with a double bond connected to atoms outside of the ring. This is
not surprising, since BASS leverages the curated set of aromatic substructures in KEGG
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and has very high precision (99.9%) in the detection of aromatic substructures in KEGG
compounds, while Indigo uses a set of simplified aromatic detection heuristics along with
hard-coded algorithmic limitations of ring sizes being searched. However, we had concerns
that some valid aromatic substructure representations in MetaCyc compounds may not
exist in the reference aromatic substructure set derived from the KEGG database, which
would be missed by the BASS method. This was confirmed by Indigo detecting 30
additional MetaCyc compounds with aromatic substructures not detected by the BASS
method. Therefore, we combined the KEGG aromatic substructures with additional Indigodetected substructures from MetaCyc. By using both methods, we were able to detect
aromatic substructures in about half of the compounds in each database (Table 2.5). When
an aromatic substructure was detected, all bonds for the aromatic substructure were
changed to an aromatic bond type and the modified molfile was saved. All analyses were
performed on a desktop computer with a i7-6850K CPU (6-core with HT), 64GB RAM,
and 512GB solid state drive. On this hardware, the aromatic substructure detection took
less than 5 minutes for KEGG and roughly 15 minutes for MetaCyc in terms of execution
time.
Table 2.4. Incomplete detection of aromatic substructures by BASS and Indigo
Databases
BASS
Indigo
KEGG
0
~1500
MetaCyc
30
~1700
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KEGG: C20727
Figure 2.6. Example aromatic substructure that cannot be detected by Indigo.
Table 2.5. Compounds with aromatic substructure
Databases
KEGG
MetaCyc
2.3.3

Count
9204 (49.4%)
8292 (40.9%)

Generating identifiers for atoms using a graph coloring method
Since symmetric atoms share the same neighbors, the graph coloring method is

guaranteed to create the same identifier for them. Our concern is whether atoms with the
same identifier are actually symmetric. In our graph coloring method, we only include
0_layer identifiers in atom coloring to avoid long name strings. In some extreme cases, this
shortcut can assign the same identifier to atoms that are asymmetric. An example is shown
in Figure 2.7 A. We can see that this compound does not contain any symmetric atoms.
Without considering the upper right ring, the bottom two rings are symmetric. Therefore,
atoms 1 and 2 have the same 0_layer identifier, which is the same for atom pairs 4 & 5 and
6 & 7. In addition, once atoms 1 and 2 reach atom 3, they will share the same route to the
upper right substructure. Finally, atoms 1 and 2 will share the same coloring identifier
(Figure 2.7 B) even though they are not symmetric. To deal with this problem, atom
coloring validation and recoloring is performed. We can see that atoms 1 and 2 have distinct
identifiers after recoloring (Figure 2.7 C).

27

A

6

7

4
1

3

5
2

KEGG: C10782
B

'C(C(C,1)(N,1))(C(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)
(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,1
)(C,1)(N,1)C(C,1)(C,1)(N,1)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1
)C(C,4)(C,4)N(C,1)(C,4)(C,4)N(C,1)(C,4)(C,4))(C(C,1)(C,4)(N,4)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,4)(C,4)C(C,4)(N,4)(O,1))(C(C,4)
(C,4)C(C,4)(C,4)C(C,4)(C,4)N(C,1)(C,4)(C,4)O(C,1))(C(C,4)(C,4)C(C,4)(N,4)(O,1)C(C,4)(N,4)(O,1))': [1, 2]

C

'C(C(C,1)(N,1))(C(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(
C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,1)
(C,1)(N,1)C(C,1)(C,1)(N,1)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)
C(C,4)(C,4)N(C,1)(C,4)(C,4)N(C,1)(C,4)(C,4))(C(C,1)(C,4)(N,4)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,4)(C,4)C(C,4)(N,4)(O,1))(C(C,4)(
C,4)C(C,4)(C,4)C(C,4)(C,4)N(C,1)(C,4)(C,4)O(C,1))(C(C,4)(C,4)C(C,4)(N,4)(O,1)C(C,4)(N,4)(O,1))(C,1)(N,1)C(C(C,1)(C,1))(C(C,1
)(C,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)(N,1)C(C,1)(C,1)(N,1)C(C,1)(
N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,
1)(C,4)(C,4))(C,1)(C,1)N(N(C,1)(C,1)(C,1))(C(C,1)(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,
1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)(N,1)C(
C,1)(C,1)(N,1)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1
)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,4)(C,4)N(C,1)(C,4)(C,4)N(C,1)(C,4)(C,4))(C,1)(C,1)(C,1)': [1]
'C(C(C,1)(N,1))(C(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(
C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,1)
(C,1)(N,1)C(C,1)(C,1)(N,1)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)
C(C,4)(C,4)N(C,1)(C,4)(C,4)N(C,1)(C,4)(C,4))(C(C,1)(C,4)(N,4)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,4)(C,4)C(C,4)(N,4)(O,1))(C(C,4)(
C,4)C(C,4)(C,4)C(C,4)(C,4)N(C,1)(C,4)(C,4)O(C,1))(C(C,4)(C,4)C(C,4)(N,4)(O,1)C(C,4)(N,4)(O,1))(C,1)(N,1)C(C(C,1)(C,1))(C(C,1
)(C,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)(N,1)C(C,1)(C,1)(N,1)C(C,1)(
C,4)(N,4)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,4)(C,4)N(C,1)(C,1)(C,1)N(C,1
)(C,1)(C,1)N(C,1)(C,4)(C,4))(C,1)(C,1)N(N(C,1)(C,1)(C,1))(C(C,1)(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1
)(C,1)(C,1)C(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1)N(C,1)(C,1)(C,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)C(C,
1)(C,1)(N,1)C(C,1)(C,1)(N,1)C(C,1)(C,4)(N,4)C(C,1)(N,1)C(C,1)(N,1)C(C,1)(N,1))(C(C,1)(C,1)C(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(
C,1)(C,1)C(C,1)(C,1)(C,1)C(C,1)(C,1)(C,1)C(C,4)(C,4)N(C,1)(C,4)(C,4)N(C,1)(C,4)(C,4))(C,1)(C,1)(C,1)': [2]

Figure 2.7. Example of compound with same atom identifier for asymmetric atoms using
an overly simplistic coloring approach.
A) KEGG compound C10782; B) The atom identifiers for atoms 1 and 2 before symmetry
validation; C) The atom identifiers for atoms 1 and 2 after symmetry curation.
We validate symmetry after a first round of coloring, recolor the compound if
asymmetric atoms have the same identifier, and verify symmetry again. After this coloringvalidation-recoloring-validation process, our results indicated that the graph coloring
method is able to generate the same identifier for symmetric atoms and asymmetric atoms
have unique identifiers for all compounds in both KEGG and MetaCyc databases.
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2.3.4

Detection of correspondences between KEGG and MetaCyc compounds via
coloring identifiers.

After creating a single set of atom identifiers for each compound, we were able to derive
ordered compound coloring identifiers at different levels of chemical specificity, which
can be used to harmonize compounds across databases. Since KEGG and MetaCyc can
include different numbers of H (hydrogen atoms) in the molfile, we exclude H in coloring
at this point. We first tried to include information of bond stereochemistry, atom charge,
atom stereochemistry, and isotope stereochemistry in coloring to ensure each compound
has a unique name. With the relatively specific coloring identifiers, 1763 correspondences
between KEGG and MetaCyc compounds can be detected (see Table 2.6), which is not
satisfactory compared to 5681 pairs discovered by other identifiers (e.g. KEGG, CHEBI,
and InChI as shown in Table 2.3). This lack of correspondence is due to the inconsistencies
in bond stereochemistry, atom charge, atom stereochemistry, and isotope stereochemistry
information between these two databases. An example shown in Figure 2.8, where
compound CPD-20570 in MetaCyc has a direct reference to KEGG compound C13014.

MetaCyc: CPD-20570

Harmonized

KEGG: C13014

Figure 2.8. Example of charge inconsistency of compound representations between
databases.
The middle harmonized compound representation enables loose coloring that facilitates
compound harmonization.
For the following analysis, we only included information of atom type and bond
type to keep the backbone of a compound in atom naming. It took less than 10 minutes of
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execution time on a desktop computer with a i7-6850K CPU (6-core with HT), 64GB RAM,
and 512GB solid state drive to generate these coloring identifiers for all compound entries
in the KEGG and MetaCyc databases. About 8865 correspondences between KEGG and
MetaCyc are detected (see Table 2.6 and spreadsheets in supplementary material), and
5451 of them can be confirmed by other identifiers. With both tight and loose compound
coloring identifiers, about 95.95% compounds pairs detected by other chemical IDs can be
discovered. We manually checked the compound pairs that were discordant with other
chemical IDs and found that none of them are caused by an inconsistency between the
coloring identifier and the compound representation. The question then becomes how to
validate the remaining 3414 possible pairs. Matched compounds are supposed to take part
in the same metabolic reactions. The Enzyme Commission (EC) number is a numerical
classification scheme for enzymes, playing a key role in classifying enzymatic reactions[97,
98]. We expected matched compounds to take part in metabolic reactions with similar EC
numbers.
Table 2.6. Matched compounds detected by the compound coloring identifiers
Identifiers
Color matched pairs
ID verified pairs
Tight coloring identifier
1763
1448
Loose coloring identifier
8865
5451

Then, we analyzed the metabolic reactions in KEGG and MetaCyc databases (see
Table 2.7). We can see that the documentation of EC number in KEGG is more complete
compared to MetaCyc, but the number of metabolic reactions in MetaCyc is 50% larger
than in KEGG. Around 80% of reactions in both databases can be related to at least a 3leveled EC number.
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Table 2.7. Matched compounds detected by the compound coloring identifiers
EC types
KEGG (count / percentage)
MetaCyc (count / percentage)
No EC
1263 / 11.05%
3427 / 19.92%
1-leveled EC
24 / 0.21%
11 / 0.06%
2-leveled EC
126 / 1.10%
67 / 0.39%
3-leveled EC
1081 / 9.46%
2958 / 17.19%
4-leveled EC
8933/ 78.17%
10740 / 62.43%

Next, we tested how well EC numbers work in the validation of correspondences
between KEGG and MetaCyc compounds (See Table 2.8). We first identified colorharmonized pairs that both take part in some reactions in their respective database. There
are 4227 ID confirmed pairs and 2292 possible pairs involved in the metabolic reactions.
We further investigated if those pairs participate into the same type of reaction indicated
by EC number. If we used the first 3 levels of the sectioned EC number as the standard,
3810 (90.13%) ID-confirmed pairs are verified by 3-leveled EC numbers. In addition, 3580
of them can be further confirmed by 4-leveled EC numbers. Furthermore, 1848 and 1540
possible pairs are confirmed by 3-leveled and 4-leveled EC numbers, respectively. These
results suggest that EC numbers may be useful in validating possible pairs that have slight
coloring deviations. All of the detected compound pairs are list in Supplementary
Spreadsheet 2.1.
Table 2.8. Correspondences between KEGG and MetaCyc compounds verified by
reactions
Conditions
ID-confirmed pairs
Possible pairs
Pairs not in reaction
1224
1122
Pairs in reactions
4227
2292
Verified by 3-leveled EC
3810
1848
Verified by 4-leveled EC
3580
1540
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2.3.5

Compound representation errors and issues detected in the KEGG and MetaCyc
databases.
When harmonizing compounds between KEGG and MetaCyc databases, we found

that there are various compound representation issues and errors existing in both databases,
which can be grouped into several categories like mismatch between compound image and
molfile, incorrect cross-referencing, and different bonds attached to metal ions. Here, we
give a brief description with some examples, and all the detected inconsistency is
documented in Supplementary Spreadsheet 2.1.

2.3.5.1 Incomplete KEGG aromatic atom types.
KEGG atom types annotate every atom in every compound of the KEGG
Compound database. The KEGG atom type of an atom maps that atom to a unique chemical
substructure and these substructures often map to functional groups (e.g. the atom type
“O1a” represents an oxygen of a hydroxyl group). However, the set of KEGG atom types
are not complete, especially with regard to aromatic heterocycle atoms. In particular, there
are no oxygen and sulfur aromatic KEGG atom types defined, which prevents full
automation of aromatic substructure determination based on KEGG atom type alone. We
used a simple heuristic method (i.e a simple deterministic decisioning approach) to
consider oxygen and sulfur atoms as aromatic when they are part of a ring where all other
carbon and nitrogen atoms are labeled as aromatic, based on KEGG atom types. But this
aromatic substructure detection approach has limitations that requires some manual
inspection, as highlighted in Figure 2.9. KEGG Compound entry C03861 contains a 1,432

dioxin flanked by aromatic rings. The 1,4-dioxin is not aromatic. In a counter-example,
KEGG Compound entry C07729 contains an aromatic pyridine substructure flanked by
benzyl rings.

The presence of both examples illustrates why aromatic substructure

detection cannot be fully automated based on the current set of KEGG aromatic atom types.
In addition, Figure 2.10 shows a KEGG compound with an S-containing aromatic ring.
As an aside, the quinoid fragment in KEGG Compound entry C03861 is likely
mislabeled as aromatic, since quinoid fragments are standardly antiaromatic[99]. This
quinoid fragment was likely mislabeled as aromatic due to the whole three-ring structure
obeying Huckel’s rule. While we treated KEGG-identified aromatic substructures as
completely correct, this example does indicate the presence of some error in KEGG’s
aromatic substructure detection methods. Comparison of Indigo to KEGG may provide a
means for detecting suspect KEGG aromatic substructures, but a manual inspection of all
suspect substructures is not practical, especially from an automated analysis perspective.
Moreover, aromatic mislabeling should not impact compound harmonization if applied
consistently across databases.

KEGG: C03861

KEGG: C07729

Figure 2.9. Compound with incomplete KEGG aromatic atom types.
The middle ring of compound C03861 (left) is not aromatic while the middle ring of
compound C07729 (right) is aromatic.

Figure 2.10. KEGG compound with S-containing aromatic ring.
33

2.3.5.2 Inconsistent compound representations.
Using ID-based compound harmonization, we found that there are about 10
MetaCyc compounds that contain valid aromatic substructures not detected by either the
BASS or Indigo methods (Figure 2.11). To deal with this problem, we incorporated those
valid aromatic substructures into the reference aromatic substructure set.

MetaCyc: CPD-15916

KEGG: C02380

Figure 2.11. Compound with different aromatic representations.
These two corresponding compound entries across KEGG and MetaCyc have two different
aromatic substructure representations.
2.3.5.3 Incorrect cross-referencing
There are some matched compounds detected by other identifiers that don’t have
the same coloring identifier. Compound CPD-19437 in MetaCyc has a direct reference to
KEGG compound C12187, but their coloring identifiers are different (see Figure 2.12). We
can see that the compound representation in MetaCyc is not consistent with its counterpart
in KEGG. In addition, CPD-19437 and C12187 have the same ChEBI reference compound
32074, and the representation in ChEBI is the same with that of KEGG, suggesting the
representation in MetaCyc may be incorrect.
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MetaCyc: CPD-19437

KEGG: C12187

ChEBI: 32074

Figure 2.12. Example of inconsistent compound representations between KEGG and
MetaCyc.
2.3.6

Estimating the error rate of the graph coloring method.
2.3.6.1 Ambiguous coloring identifiers.
During the compound harmonization process, tight atom and compound coloring

was loosened (see Figure 2.8 for an example), keeping only atom type and bond type in the
atom coloring for the final steps in compound harmonization. With the loose coloring,
multiple compounds in one database can have the same coloring identifier. We first tested
if a compound can have a unique coloring identifier when all information is included in the
atom coloring with hydrogen (H) atoms excluded (Table 2.9). Here, we did not count
compounds with a generic R group representing ambiguous functional groups and
substructures; however, the results that include all compounds are described in Table 2.10.
Several types of compounds cannot be distinguished by the tight coloring identifier except
for those duplicates (Figure 2.13). When we only include atom type and bond type in the
atom coloring, many more compounds share the same coloring identifier. After compound
harmonization, we are able to detect compounds with the same coloring identifier from the
source database.
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Table 2.9. Compounds with the same coloring identifier, excluding R groups
Databases
Tight coloring identifier
Loose coloring identifier
KEGG
99 (0.5%)
968 (4.8%)
MetaCyc
117 (0.6%)
1144 (5.6%)
Table 2.10. Compounds with the same coloring identifiers, which includes R groups.
Databases
Tight coloring identifier
Loose coloring identifier
KEGG
209 (1.1%)
1132 (6.1%)
MetaCyc
449 (2.4%)
1638 (8.1%)

B

A

KEGG: C02389

KEGG: C00530

C

KEGG: C00484

KEGG: C00083

KEGG: C03188

D

KEGG: C01402
KEGG: C04353

KEGG: C04350

E

KEGG: C01756

KEGG: C02380

Figure 2.13. Representative compounds that cannot be distinguished by coloring identifier.
A) Compound and its radical form; B) Compound containing repeated substructure; C)
Compound with R representing a generic group; D) Isomers containing C=N; E)
Compounds after curation of aromatic substructures.
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When the compound identifier is ambiguous, a compound in one database can be
mapped to several different compounds in the other database during compound
harmonization. For ID confirmed pairs, 28 MetaCyc compounds can be linked to more than
one KEGG compound, which is caused by inconsistency of different ID references. Also,
about 478 MetaCyc compounds have several KEGG correspondences among the 1848
pairs verified by 3-leveled EC. This highlights the value in leveraging metabolic reactions
and the corresponding atom mappings to disambiguate multiple possible mappings while
constructing an integrated metabolic network.
2.3.6.2 Pseudosymmetric atoms.
Omitting information in the atom coloring can also lead to pseudosymmetric atoms.
We tested if incorporation of atom charge, atom stereochemistry, or bond stereochemistry
in the atom coloring will erase some symmetric atoms (Table 2.11). After addition of atom
charge, 148 MetaCyc and 38 KEGG compounds lose symmetry. Most of them are caused
by terminal atoms, like CPD-321 (Figure 2.14). Since either symmetric atom can be labeled
with charge, asymmetry caused by atom charge can be ignored in constructing metabolic
network. In addition, both databases contain compounds affected by bond and atom
stereochemistry. We need to take bond and atom stereochemistry into consideration, since
some enzymes are stereochemically specific. A heuristic method could be used to test if
symmetric atoms are affected by bond and atom stereochemistry, and then atom coloring
identifiers incorporated with bond and atom stereochemistry will be generated to overcome
this issue. However, more complex molecular symmetries like that illustrated by KEGG
C04167 will require the use of algorithms that can detect all possible molecular symmetries
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(i.e. automorphisms induced by rotations and reflections of the 3 embedded graph) using
a 3-dimensional representation of the compound[100].
Table 2.11. Compounds gaining asymmetry after addition of extra information in the atom
naming
Atom
Bond
Databases
Atom charge
stereochemistry
stereochemistry
KEGG
232
38
169
MetaCyc
219
148
227

KEGG: C04167

MetaCyc: CPD-321

Figure 2.14. Example compounds gaining asymmetry after the addition of tight atom
coloring information.
For CPD-321, the two oxygens bound to the nitrogen are asymmetric with tight atom
coloring and symmetric with loose atom coloring.

2.3.6.3 Changeable graph representation.
There are two types of matched compounds that cannot be detected by coloring
identifiers. One group of compounds can have either linear or circular representations (see
Figure 2.15), and there are about 26 examples in this category. The other group is caused
by resonance structures (see Figure 2.16), and we discovered about 46 similar cases.
Artificial sets of atom mappings can be created to represent chemical transformations that
are spontaneous.
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MetaCyc: MEVALDATE

KEGG: C00772

Figure 2.15. Compound with linear and circular representations.

MetaCyc: CPD-6543

KEGG: C11343

Figure 2.16. Compound with different resonance structures.
2.4

Discussion
Here, we have developed a graph coloring method that creates unique identifiers for

each atom in a compound with consideration for molecular symmetry. The atom-specific
identifiers can capture additional cross-reaction atom mappings caused by symmetric
atoms, which will contribute to the construction of a more complete atom-resolved
metabolic network requiring information at both the compound and atom levels. Towards
this overall goal, the ordered compound coloring identifiers derived from the
corresponding atom coloring identifiers facilitate compound harmonization across
metabolic databases, which is an essential first step in cross-database network integration.
Different databases can have distinct preference in compound representations, especially
for aromatic substructures. To overcome inconsistent aromatic representations between
databases, we devised a pragmatic BASS method[89] for aromatic substructure detection
that leverages the labeled aromatic substructures in KEGG. Application of BASS to KEGG
validated the method, providing confidence in its application to the MetaCyc database. The
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automatic aromatic atom detection method in Indigo[87] further validated the
comprehensiveness of our BASS aromatic substructure detection method that leverages
KEGG’s curated aromatic substructures, and the combination of BASS and Indigo can
achieve good performance in aromatic substructure detection. This was further augmented
by detecting additional aromatic substructure representations in MetaCyc through IDbased compound harmonization. In addition, compound states such as atom charge are not
always the same between KEGG and MetaCyc. Therefore, identifiers like InChI that
include these details to achieve an unambiguous label are not a good choice for maximizing
cross-database compound harmonization in this situation. Furthermore, InChI cannot
handle the compound entries that contain R-groups. However, InChI is very useful for
validation of the presented methods development. Simplified molecular-input line-entry
system (SMILES) identifiers and its derivatives are not a good option, because SMILES
and its derivatives are not guaranteed to generate a unique identifier. Also, neither InChI
nor SMILES deal with the unique naming of atoms that is consistent for symmetric atoms.
While the molecular graph coloring method has similarities to molecular canonicalization
methods[93, 101, 102], it was designed to facilitate harmonization of compounds between
metabolic databases. The graph coloring method is flexible in adjusting information used
in atom coloring, which can help detect more possible matched compounds with a higher
false positive rate. With the coloring identifiers, we were able to detect 8865
correspondences between KEGG and MetaCyc compounds, and 5451 of them can be
confirmed by other identifiers. In addition, commonality in EC numbers associated with
reactions and compounds provided another avenue for both validating and predicting
possible correspondence pairs. This method validated 1848 pairs unconfirmed by other
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identifiers. While harmonizing compounds between KEGG and MetaCyc, we detected
various issues and errors in the databases by coloring identifiers which are enumerated in
the supplemental material, suggesting that this method can also be used for curation of
current metabolic databases. Furthermore, the graph coloring method and compound
harmonization approach can be used to integrate any metabolic database that provides a
molfile representation of compounds, greatly facilitating future construction of more
complete integrated metabolic networks.
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CHAPTER 3. HIERARCHICAL HARMONIZATION OF METABOLIC REACTIONS ACROSS
METABOLIC DATABASES

3.1

Introduction
Metabolic models describe the inter-conversion of metabolites via biochemical

reactions catalyzed by enzymes, providing snapshots of the metabolism under a given
genetic or environmental condition[103, 104] . Metabolic models of metabolism have
proven to be an important tool in studying systems biology and have been successfully
applied to various research fields, ranging from metabolic engineering to system medicine
[105-109]. Advances in analytical methodologies like mass spectroscopy and nuclear
magnetic resonance greatly improve the high-throughput detection of thousands of
metabolites, enabling the generation of large volumes of high-quality metabolomics
datasets [48, 110] that greatly facilitate metabolic research. As a next major step,
incorporating reaction atom-mappings into metabolic models enables metabolic flux
analysis of isotope-labeled metabolomics datasets[53, 65, 69, 70], which will contribute to
the large-scale characterization of metabolic flux molecular phenotypes and prediction of
potential targets for gene manipulation[106]. Building reliable metabolic models heavily
depend on the completeness of metabolic network databases. However, a relatively
complete metabolic network, especially at an atom-resolved level, is practically not
available [72].
Therefore, to construct an atom-resolved metabolic network, the very first major step
is to integrate metabolic data from various metabolic databases without redundancy[82],
which remains extreme labor-intensive. This is partially due to problems in the individual
databases[111]. Common issues include non-unique compound identifiers, reactions with
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unbalanced atomic species, and enzyme catalyzing more than one reaction[112]. Moreover,
incompatibilities of data representations (like compound identifiers) and incomplete
atomistic details (like the presence of R groups and lack of atom and bond stereochemistry)
across databases are key bottlenecks for the rapid construction of high-quality metabolic
networks[113]. Great efforts have been made to map different compound identifiers across
metabolic databases[114, 115]. Some algorithms use logistic regression to compute the
similarity between strings generated by concatenating a variety of compound features,
which requires careful selection of compound features that can well characterize a string
pair by capturing the similarity between different variations as well as underlining the
difference between descriptions which are not synonymous[108]. Alternatively, utilization
of unique chemical identifier independent from a particular database, like InChI[93, 116]
or SMILES[117], have been suggested as an important step in harmonizing metabolic
databases[118]. However, several tricky cases still remain unresolved. For example, InChI
cannot handle the compound entries that contain R-groups.
Our neighborhood-specific graph coloring method can derive atom identifiers for
every atom in a specific compound with consideration of molecular symmetry, facilitating
the construction of an atom-resolved metabolic network[119]. Furthermore, a unique
compound coloring identifier can be generated based on the atom identifiers, which can be
used for compound harmonization across metabolic databases. The results derived from
the compound coloring identifiers were quite promising. However, issues like incomplete
atomistic details were not completely handled in that prior work.
To put this paper into context with our prior published work, we first developed the
subgraph isomorphism detection algorithm CASS (Chemically Aware Substructure Search)
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in 2014[89] and have made multiple improvements to this code base over the years and
now call it BASS (Biochemically Aware Substructure Search). In developing our
neighborhood-specific graph coloring method, we further enhanced BASS to efficiently
detect aromatic substructures which was required for that work. In this chapter, we further
optimized the subgraph isomorphism detection algorithm CASS (Chemically Aware
Substructure Search)[89] to aid in the validation of generic compound pairs. In addition,
we solved inconsistent atomistic characteristics across databases by defining a set of
harmonization relationship types between compounds, aiming to capture chemical details
while maintain compound pairs at various levels. Furthermore, we used the classification
of compound pairs and EC (Enzyme Commission) numbers to harmonize metabolic
reactions across Kyoto Encyclopedia of Genes and Genomes (KEGG) and MetaCyc
metabolic pathway databases via establishing hierarchical harmonization relationships
between metabolic reactions. We further made use of the atom identifiers to evaluate atom
mapping consistency of these harmonized reactions. Through this analysis, we detected
some issues that cause the inconsistency of reaction atom mappings both within and across
databases. The generalization of metabolic reactions can be applied to various interesting
topics including but not limited to predicting biotransformation of newly discovered
metabolites[120], devising novel synthetic pathways of essential metabolites[121], and
bridging gaps in the current metabolic network[122]. Furthermore, expanding the existing
metabolic network by integrating other metabolic databases can be easily achieved when
the molfile representations[76] of compounds are provided.
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3.2
3.2.1

Materials and Methods
Compound and Metabolic Reaction Data
All data were downloaded directly from KEGG and MetaCyc databases. MetaCyc

compound and reaction data downloaded from BioCyc is in version 23.0. The KEGG
COMPOUND, KEGG REACTION and KEGG RCLASS data is from the version available
from KEGG on April 2021 via its REST interface. KEGG RPAIR data was downloaded
from KEGG database in 2016.
3.2.2

Curation of molfile
The documentation of atom stereochemistry in the molfiles is not complete. We used

Open Babel[91] to curate the original molfiles and add stereospecific information.
3.2.3

Identification of double bond stereochemistry
We previously adopted a method for automated identification of double bond

stereochemistry[90]. One limitation of this method is that only double bonds between two
carbon atoms can be handled. For example, double bonds connected by heterogenous
atoms, like N=C, cannot be processed by the method. Here, we designed a new algorithm
to distinguish cis/trans stereoisomers. The same criteria are applied to assign priority to
each group attached to the double bond. If one side of the double bond only has one group,
this group will be prioritized. Next, the 2D plane of the compound representation is divided
into two parts with line crossing the double bond. If the prioritized groups of both sides are
on the same part of the divided plane, the double bond is labeled as cis; otherwise, it is
trans.
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3.2.4

Flowchart of steps in the compound and reaction harmonization process
The flowchart of steps in compound and reaction harmonization is shown in Figure

3.1. The initial compound pair list is composed of compound pairs detected by the loose
compound coloring identifiers. Next, reaction harmonization is conducted with the
compound pair list. Two criteria are obeyed in reaction harmonization: the two reactions
should share at least one EC number and all compounds in the two reactions are paired
unless one reaction has an extra compound entity, like H+. Apart from valid reaction pairs,
reaction pairs with the same EC number and some unmatched compounds are also
extracted. We hypothesized that those unmatched compounds are likely to be compound
pairs. Validation is conducted for the unmatched compounds, and the valid compound pairs
are added to the compound pair list. Every time the compound pair list is updated, the
above process is repeated until no new compound pairs are discovered.
Compound pair list

Reaction harmonization

Valid reaction pairs: same EC
with paired compounds.

Possible reaction pairs: same EC with
some unmatched compounds

Possible compound pairs

Validation of compound pairs

Figure 3.1. Flowchart of compound and reaction harmonization.
3.2.5

Validation of tautomers
Most common form of tautomerization involves a hydrogen changing places with a

double bond. Based on this transformation, the following steps are performed to validate if
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two compounds with same chemical formula are tautomers. To eliminate the difference
caused by single and double bonds in the structural representation, all the double bonds are
converted into single bonds, and the subgraph isomorphism detection algorithm[89] is used
to check if two structural representations are the same after modification. Next, double
bonds at unmatched positions are examined. If all the mismatches are caused by possible
tautomerization, the compound pair is considered valid. Finally, other chemical details not
related to atoms in the changeable positions are compared to classify the relationship
between valid pairs.
3.2.6

Validation of generic compound pairs of compounds with different chemical
formula.
For two compounds A and B, the subgraph isomorphism detection algorithm[89] is

used to verify if the graph representation of A (ignoring R and H) is contained in the graph
representation of B. Then, each unmatched branch in B is examined if it corresponds to an
R group in A. Compound pairs that meet both criteria are considered valid. Next, the
chemical details (atom and bond stereochemistry) in the two compounds are compared for
relationship type classification. If the chemical details of compound A are included in
compound B, then A has a generic-specific relationship to B; otherwise, A and B have a
loose relationship.
3.2.7

Validation of compound pairs with linear and circular representations.
The compound with changeable linear and circular structures are common in small

molecule carbohydrate metabolites, like glucose. This conversion occurs due to the ability
of aldehydes and ketones to react with alcohols. To validate the compound pairs with linear
and circular representations, we first locate the bond in the circular structure that is formed
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by connecting the C in the aldehyde (keto) group and O in the hydroxy group. The
following steps include breaking the newly formed bond and restoring the C=O bond in
the aldehyde (keto) group. Then, a new compound coloring identifier is generated for the
modified circular representation. If the updated compound coloring identifiers match, the
compound pair is considered valid.
3.2.8

Parse of KEGG RCLASS RDM patterns.
Based on the RDM patterns, we first identified the possible atoms that can be mapped

to each reaction center. Then we derived the possible combinations of atoms for all the
reaction centers for each compound. We paired cases in either compound, removed
changed bond in the compound according to different region, and detected the maximum
common subgraph of the remaining structures. We examined all the combinations and
derived the optimal mappings with the maximum number of mapped atoms and least ratio
of changed atoms.

3.3

Results

3.3.1

Overview of KEGG and MetaCyc databases

The compounds in the KEGG and MetaCyc databases are summarized in Table 3.1.
Based on the atomic composition, we divided compounds into two groups: specific
compounds (no R group) and generic compounds (with presence of R group(s)). About
8.02% KEGG compounds and 21.72% MetaCyc compounds contain R groups.
Table 3.1. Summary of KEGG and MetaCyc compound databases.
Compound Type
KEGG
MetaCyc
specific compounds
16529 (91.98%)
15859 (78.28%)
generic compounds
1441 (8.02%)
4400 (21.72%)
Total
17970 (100%)
20259 (100%)
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According to the classification of compounds, we also categorized the atom-resolved
metabolic reactions into two sets: specific reactions where all compounds in the reaction
are specific compounds and generic reactions which contain at least one generic compound.
Here, we only considered reactions with relatively complete EC numbers[97, 123] since
consistent EC number is one essential component in reaction harmonization. From Table
3.2, we can see that about 15% KEGG reactions and 34% MetaCyc reactions are generic
reactions.
Table 3.2. Summary of KEGG and MetaCyc atom-resolved metabolic reaction databases
Reaction Type
KEGG
MetaCyc
specific reactions (4-leveled EC)
6780 (75.26%)
6397 (49.93%)
specific reactions (3-leveled EC)
886 (9.83%)
2022 (15.78%)
generic reactions (4-leveled EC)
1244 (13.81%)
3572 (27.88%)
generic reactions (3-leveled EC)
99 (1.10%)
822 (6.42%)
Total
9009 (100%)
12813 (100%)
We further did a simple quality check of the atom-resolved reactions in KEGG and
MetaCyc databases (Table 3.3). KEGG contains about 7.5% incomplete reactions where
the number of atoms on both sides of the reaction is different. For MetaCyc, less than 0.5%
reactions have incorrect atom mappings caused by mapping different atoms of different
elements. In addition, a large amount of reactions only have part of atoms mapped in both
KEGEG and MetaCyc databases. This level of incompleteness prevents their effective use
in mass balanced metabolic modeling.
Table 3.3. Quality check of atom-resolved reactions in KEGG and MetaCyc.
Incomplete
Incorrect Atom
Incomplete
Database
Reaction
Mappings
Atom mappings
KEGG
772 (7.53%)
0
7213 (70.36%)
MetaCyc
0
54 (0.37%)
6130 (41.87%)
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3.3.2

Results of compound harmonization across KEGG and MetaCyc databases
With the loose compound coloring identifiers generated by the neighborhood-

specific graph coloring method, about 8865 compound pairs were detected, including both
generic and specific compound pairs [119]. However, some cases were not solved perfectly
by the loose compound coloring identifiers. First, chemical details like atom and bond
stereochemistry were ignored in the loose compound coloring identifies. Second, a
compound pair can involve a generic compound and a specific compound (Figure 3.2),
which cannot be discovered by the loosing compound coloring identifiers. The methyl
group in KEGG compound C01042 can be a specification of the R group in MetaCyc
compound CPD-576. What makes things more complicated is that a compound pair can be
composed of two generic compounds with different atom composition. In Figure 3.3, even
though both compounds contain an R group, the MetaCyc compound 3-Acyl-pyruvates can
be regarded as a subgroup of compounds belonging to KEGG compound C00060. In
addition, compound pairs with different structural representations, like tautomers, were
missed by the loose compound coloring identifiers.

MetaCyc: CPD-576

KEGG: C01042

Figure 3.2. Compound pair of generic and specific compounds.
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KEGG: C00060

MetaCyc: 3-Acyl-pyruvates

Figure 3.3. Compound pair of generic compounds.

3.3.2.1 Harmonization of specific compounds.
We first incorporated the chemical details, including atom stereochemistry and
bond stereochemistry to evaluate the specific compound pairs detected by loose compound
coloring identifiers. Incorporation of the chemical details can lead to three scenarios: 1) the
paired compounds have the same set of chemical details; 2) the chemical details of one
compound are the subset of the other compound; 3) the chemical details of the two
compounds cannot be fully matched. Based on the above cases, we decided to classify the
relationship between compound pairs as an equivalence relationship, a generic-specific
relationship, or a loose relationship. With this classification, a compound in one database
can be paired with multiple compounds in the other database with an appropriate
relationship. With these improvements incorporated into specific compound harmonization
(Table 3.4), we can see that the majority of specific compound pairs have a loose
relationship, which is not surprising since the criteria for the loose relationship were less
strict. Another explanation is that the chemical details for the same compound can be
inconsistent across databases. The MetaCyc compound CPD-399 has a direct KEGG
compound reference C03495 (Figure 3.4), but stereochemistry of some atoms in the two
compound representations are not the same.
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Table 3.4.Harmonization of specific compound pairs.
Relationship Type
equivalence
generic-specific
loose
Total

KEGG: C03495

Count
3636 (27.99%)
1712 (13.18%)
7642 (58.83%)
12990 (100%)

MetaCyc: CPD-399

Figure 3.4. Example harmonized compound pair of compounds with inconsistent chemical
details.
3.3.2.2 Harmonization of generic compounds.
Generic compounds further complicate relationships between compounds. A
generic compound can be related to generic and/or specific compounds (Figure 3.2 & 3.3).
For a compound pair of two generic compounds with the same atom composition, we
classify them based on the same criteria of specific compounds. Harmonization of generic
compound pairs of compounds with different chemical formulas is much more complicated,
involving detection and validation steps. All chemical identifiers fail in detecting the
possible pairs, including the loose compound coloring identifiers. On the other hand, it will
be very time-consuming and unnecessary to do brute-force search of all compounds across
databases.
Here, we made use of the metabolic reactions across databases to detect the possible
compound pairs with a different atom composition. We first extracted reaction pairs that
can contain at least one generic reaction and share at least one EC number. Next,
compounds with R group(s) in one reaction were paired with all the compounds in the other
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reaction. The validation method is described in the Materials and Methods section. Results
of harmonization are summarized in Table 3.5. Most of the generic compound pairs have
generic-specific relationships. This may be explained by the assumption that chemical
details in a compound with less atoms are more likely to be included in the compound
containing more atoms.
Table 3.5. Harmonization of generic compounds.
Relationship Type
equivalence
generic-specific
loose
Total

Count
126 (4.72%)
2543 (95.28%)
0
2669 (100%)

3.3.2.3 Harmonization of compounds with changeable
representations.
Harmonization of compounds with changeable representation (e.g. linear vs
circular sugar representations) also requires detection and validation. Again, metabolic
reactions were used to detect the possible compound pairs via an iterative approach. Two
criteria should be obeyed when extracting the reaction pairs: 1) the two reactions should
share at least one EC number; 2) at least a pair of compounds in the two reactions can be
matched. For those unmatched compounds with the same chemical formula, they will be
added to the possible list. The validation methods are described in the Materials and
Methods section. About 45 such compound pairs were discovered after two rounds of
iteration (Table 3.6).
Table 3.6. Harmonization of compounds with changeable representations.
Relationship Type
Count
equivalence
20 (44.44%)
generic-specific
0
loose
25 (55.56%)
Total
45 (100%)
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3.3.2.4 Summary of compound harmonization.
All compound pairs detected above were summarized in Table 3.7. In total, 15,704
compound pairs were discovered, and more than 80% of them were specific compound
pairs, roughly in agreement with the proportion of generic compounds in the database.
More importantly, about 2,669 generic compound pairs were detected, which cannot be
achieved by any existing chemical identifier.
Table 3.7. Summary of compound harmonization between KEGG and MetaCyc.
Compound Pair Type
Count
specific compound pairs
12990 (82.72%)
generic compound pairs
2669 (16.99%)
changeable compound pairs
45 (0.29%)
Total
15704 (100%)
3.3.3

Results of reaction harmonization across KEGG and MetaCyc databases.
With the harmonized compounds, we performed reaction harmonization across

KEGG and MetaCyc databases. Two criteria should be followed in reaction harmonization:
1) the two reactions should share at least an EC number; and 2) all compounds in the two
reactions should be paired unless one reaction has an extra compound entity, like H+.
Reaction pairs were further categorized into the following three relationship types based
on the classification of their compound pairs: 1) equivalence relationship when a reaction
pair included only equivalently paired compounds; 2) generic-specific relationship when a
reaction pair only included equivalently paired compounds and at least one generic-specific
compound pair that are consistently in the same general-to-specific direction; 3) loose
relationship when a reaction pair included loosely paired compounds or generic-specific
paired compounds with inconsistent general-to-specific direction.
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We first harmonized the specific metabolic reactions where both reactions are
specific reaction (Table 3.8). We can see that reaction pairs in group 3 take up more than
70%, which is quite consistent with the classification of specific compound pairs. About
60% of specific compound pairs are loosely matched (Table 3.4), and a reaction pair only
requires one loosely matched compound pair to be classified into group 3.
Table 3.8. Harmonization of specific reactions between KEGG and MetaCyc.
Relationship Type
Count
equivalence
718 (24.00%)
generic-specific
68 (2.27%)
loose
2205 (73.72%)
Total
2991 (100%)

We also analyzed the generic reaction pairs where at least one reaction is generic.
Above 70% generic reaction pairs are in group 2 (Table 3.9), which can also be well
explained by the previous result that around 95% generic compound pairs have a genericspecific relationship.
Table 3.9. Harmonization of generic reactions between KEGG and MetaCyc.
Relationship Type
Count
equivalence
29 (6.03%)
generic-specific
344 (71.51%)
loose
108 (22.45%)
Total
481 (100%)
Since the EC information is not very complete in both databases, some reaction
pairs can be ignored due to the mismatch or miss of the last level EC. To avoid missed
pairs, we relaxed the first criterion in reaction harmonization to “the two reactions should
have at lease a pair of EC numbers that share the first 3 levels”. The newly discovered
reaction pairs are summarized in Table 3.10, including both specific and generic reaction

55

pairs. Either mismatch or miss of last EC occur in some reaction pairs. Specific examples
are shown in Figure 3.5 & 3.6.
Table 3.10. Loose harmonization of reactions between KEGG and MetaCyc.
Relationship Type
Count
equivalence
49 (12.76%)
generic-specific
96 (25.00%)
loose
239 (62.24%)
Total
384 (100%)

A

B

Figure 3.5. Reaction pair with mismatch of last EC number.
A)
MetaCyc
reaction
6.2.1.34-RXN
with
EC
number
6.2.1.34
(https://metacyc.org/META/NEW-IMAGE?object=6.2.1.34-RXN&&redirect=T);
B)
KEGG reaction R02194 with EC number 6.2.1.12 (https://www.genome.jp/entry/R02194).
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A

B

Figure 3.6. Reaction pair with missing 4th-level EC number designation.
A)
MetaCyc
reaction
ACETCAPR-RXN
with
EC
number
2.6.1.(https://metacyc.org/META/NEW-IMAGE?object=ACETCAPR-RXN&&redirect=T);
B)
KEGG
reaction
R04029
with
EC
number
2.6.1.65
(https://www.genome.jp/entry/R04029).
The results of reaction harmonization are shown in Table 3.11. Overall, 3,856
reaction pairs were detected via EC numbers and integrated compound pairs. The majority
of reaction pairs are specific. About 10% of reactions pairs can be missed due to incomplete
and inconsistent EC numbers.
Table 3.11. Summary of reaction harmonization between KEGG and MetaCyc.
Relationship Type
Count
specific
2991 (77.57%)
generic
481 (12.47%)
loose EC
384 (9.96%)
Total
3856 (100%)
3.3.4

Comparison of KEGG RCLASS and RPAIR data
For the KEGG database, the RCLASS data describes the chemical transformation

of substrate-product in the RDM pattern [124]. A RDM description can be divided into
three parts: reaction center (R), the different region (D), and the matched region (M). In
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order to distinguish functional groups and microenvironment of atoms, KEGG classified
atomic species of C, N, O, S, and P into 68 types (KEGG atom types)[88], which are
implemented in the RDM description. As shown in Figure 3.7, The RCLASS entry
RC00003 contains one RDM description. The S atom is the reaction center, the C1a in the
first substructure belongs to the different region, and those C1b atoms are in the matched
region. Based on the RDM pattern, we derived the atom mappings for specific reactantproduct compound pairs based on a common graph isomorphism search between the two
compounds limited by RDM description. We successfully parsed atom mappings for
10,212 (out of 10,313) compound pairs. There are 76 compound pairs that cannot be
deciphered due to the incorrect or missing descriptions of reaction centers. For complicated
compound pairs with multiple reaction centers, each reaction center can be mapped to
several different atoms, which in a few instances causes a serious combinatorial issue that
is impossible to address in a reasonable amount of time. An example is shown in Figure
3.8. Roughly 1013 possible cases can be derived based on the RDM descriptions. In total,
25 compound pairs cannot be processed owing to this combinatorial problem (Table 3.12).
KEGG used to archive the atom mappings between the reactant-product compound pairs
in the RPAIR database, where the mapped atoms are specified by the atom numbering for
a compound pair. Here, we evaluated the atom mappings derived from RCLASS and an
older version of KEGG RPAIR. The majority (great than 86%) of atom mappings between
RCLASS and RPAIR are the same (Table 3.13). To further validate the results, we
calculated the fraction of atom mappings with changed local bonded chemical environment
across the mapping (i.e., atom mappings with changed one-bond atom color) in terms of
the total number of mapped atoms in the reaction. The expectation is that this fraction
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represents the fraction of reaction center atoms present where a chemical bond is changed
or broken. Then, we generated a scatter plot of changed local atom color fraction for KEGG
RPAIR versus RCLASS atom mappings. From Figure 3.9 A, we can see that the majority
compound pairs have the same fraction of changed local atom color (concentrated on the
diagonal line). In addition, more atom mappings derived from RPAIR have a higher ratio
of changed atoms. We figured out that the majority of the inconsistency is due to the
interchangeable mappings of resonant atoms, like the O atoms in the carboxyl group
(Figure 3.10). After further curation to handle resonant atoms (Table 3.14), about 94%
compound pairs have the same atom mappings. From Figure 3.9 B, we can see that quite
large portion of compound pairs with higher ratio of changed atoms in RPAIR disappear.
The remaining 557 inconsistent mappings appear to come from two different issues. One,
more than 93% of the remaining inconsistent mappings (517 out of 557) are likely caused
by the updating of the KCF (molfile like) files or associated molfiles in KEGG database
from continual curation. For example, the RDM description for compound pair
C01255_C02378 has been updated in the RCLASS (Figure 3.11). We also plotted the
changed one-bond atom color fraction for compound pairs with RDM update (Figure 3.9
C). Compound pairs in either RCLASS or RPAIR can have higher changed atom ratio. The
fraction of changed local atom color appears to equally distributed above and below the
diagonal red line, which is interesting since the update of RDM descriptions is a correction
process in KEGG database and may reflect both changes in specific mapped atoms and
changes in the overall proportion of atoms mapped. Two, we found that a compound
representation can vary across different compound pairs. Therefore, we hypothesize that a
lack of synchronization between compound and compound_pair representations over time
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has caused the observed atom mapping inconsistencies detected in most of the other 40
compound pairs. For this part, RPAIR compound pairs show an increased fraction of
changed local atom color (Figure 3.9 D) versus its equivalent RCLASS, demonstrating that
this metric has value in evaluating atom mappings.

Figure 3.7. Example of RCLASS entry.
RCLASS RC00003 (https://www.genome.jp/dbget-bin/www_bget?rc:RC00003).
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A

B

Figure 3.8. RCLASS with combinatorial issue caused by multiple possible mappings of
RDM descriptions.
A) RDM description of RCLASS RC02715 (https://www.genome.jp/dbgetbin/www_bget?rc:RC02715); B) Compound pair C01054_C08626 that follows the
RC02715 RDM pattern (https://www.genome.jp/Fig/reaction/R09910.gif).
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Table 3.12. Hardly interpretable compound pairs.
RCLASS
RC02715
RC00871
RC01850
RC01579
RC01851
RC01582
RC02163
RC02496
RC01862
RC01616
RC02632
RC03124
RC02708
RC01863
RC02603
RC01864
RC02714
RC02619
RC02620
RC02621
RC01901
RC02716
RC02717
RC02720
RC02722

Compound pair
C01054_C08626
C01051_C02463
C00751_C06309
C00751_C06083
C00751_C06310
C01054_C01902
C00751_C08627
C12354_C18337
C01054_C08615
C05773_C05774
C01054_C08637
C01054_C08797
C01054_C17966
C01054_C08616
C01054_C19819
C01054_C08628
C01054_C20188
C01054_C19833
C01054_C19801
C00751_C19834
C02094_C15943
C01054_C20189
C01054_C20191
C01054_C20194
C01054_C20200

Table 3.13. First-round evaluation of atom mappings of compound pairs between KEGG
RCLASS and RPAIR.
Condition
Count
8017 (86.1%)
same atom mappings
1294 (13.9%)
inconsistent atom mappings
9311 (100%)
Total
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A

B

C

D

Figure 3.9. Scatter plot of changed one-bond atom color fraction for KEGG RCLASS
versus RPAIR atom mappings in paired compounds.
(A) All compound pairs before correcting resonant atoms; (B) All compound pairs after
correcting resonant atoms; (C) Compound pairs with inconsistent atom mappings caused
by RDM update; (D) Compound pairs with inconsistent atom mappings caused by
unsynchronized representations.

2

1

1

2

Figure 3.10. Example of atoms with interchangeable mappings.
KEGG RPAIR maps atom 1 in C03618 to atom 2 in C06030 and atom 2 in C03618 to atom
1 in C06030.
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Table 3.14. Second-round evaluation of atom mappings of compound pairs between KEGG
RCLASS and RPAIR.
Condition
Count
same atom mappings
8333 (95.19%)
inconsistent atom mappings
422 (4.8%)
Total
8755 (100%)

A

B

C

Figure 3.11. Comparison of KEGG RCLASS and RPAIR description for compound pair
C01255 and C02378.
A)
Compound
C01255
and
C02378
(https://www.kegg.jp/keggbin/rpair_image?entry=RC00090&cpair=C01255_C02378); B) KEGG RCLASS
description
for
the
compound
pair
(https://www.genome.jp/dbgetbin/www_bget?rc:RC00090); C) KEGG RPAIR description for the compound pair along
with the atom mappings.
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3.3.5

Evaluation of atom mappings between KEGG and MetaCyc databases.
The atom mappings for each reaction in the MetaCyc database are specified based

on the atom numbering of each compound in their molfile representation. For the KEGG
database, we used the atom mappings for compound pairs parsed from the RCLASS entries.
Here, we evaluated the atom mappings in about 3000 specific reaction pairs with the same
compound representations (Table 3.15). About 88% of the reaction pairs have consistent
atom mappings between the two databases. A consistent example is shown in Figure 3.12.
Table 3.15. Evaluation of atom mappings between KEGG and MetaCyc.
Condition
Count
2685 (88.0%)
same atom mappings
366 (12.0%)
inconsistent atom mappings
3051 (100%)
Total

4

4
7

5

6

5

1 2
8

6

3
71 2

3

8

9

9

Figure 3.12. Example of reaction pair with the same atom mappings.
Reaction
pair
MetaCyc
1.1.1.168-RXN
(https://metacyc.org/META/NEWIMAGE?object=1.1.1.168-RXN&&redirect=T)
and
KEGG
R03155
(https://www.genome.jp/entry/R03155) have the same atom mappings.
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We also generated a scatter plot of changed atom color fraction between paired
KEGG and MetaCyc reactions (Figure 3.13 A). For some reactions, only part of the
compounds are mapped in either database (Table 3.3). For MetaCyc, atoms are normally
mapped at a reaction level. Since the KEGG RCLASS database maps atoms at a compound
level, multiple RCLASS atom mappings must be evaluated together for a given KEGG
reaction. We also just visualized paired reactions with inconsistent atom mappings (Figure
3.13 B). We can see that the MetaCyc reactions have a higher ratio of changed local atom
color. However, the number of mapped atoms in the paired reactions are not always the
same, which can cause the fraction of changed local atom color can deviate from the
diagonal. This issue makes a direct interpretation for specific reaction pairs more difficult,
but the observed trend above the diagonal has interpretable value.
Through these comparisons, we see that both databases can contain distinct issues with
their atom mappings. Some MetaCyc reactions can have incorrect atom mappings. An
example is shown in Figure 3.14. For some KEGG reactions with single compound
involving in several compound pairs, one atom can be mapped to multiple atoms and leave
some atoms unmatched. For the KEGG reaction R10579 shown in Figure 3.15 A, based on
the RDM descriptions in the two compound pairs (Figure 3.15 B & 3.15 C), atom 1 in
compound C00251 is mapped to atom 1 in compound C00022 and atom 1 in compound
C00578, leaving atom 2 in C00251 unmapped. Compared with the corresponding MetaCyc
reaction RXN-14940 (Figure 3.16), the RDM description of KEGG RCLASS RC03212
appears incorrect. The harmonized reactions with different atom mappings are shown in
Supplementary Spreadsheet 3.1.
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A

B

Figure 3.13. Scatter plot of changed one-bond atom color fraction for KEGG versus
MetaCyc atom mappings in paired reactions.
Lighter colors represent higher overlapped point density. (A) All paired reactions are
included; (B) Reaction pairs with inconsistent atom mappings are included.

Figure 3.14. Example of MetaCyc reaction with incorrect atom mappings.
MetaCyc
1.13.11.45-RXN
(https://metacyc.org/META/NEWIMAGE?object=1.13.11.45-RXN&&redirect=T).
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A

B

C

Figure 3.15. Example of KEGG reaction with incorrect mappings.
A) KEGG reaction R10579 (https://www.kegg.jp/entry/R10597); B) KEGG RCLASS
RC02148 (https://www.kegg.jp/entry/RC02148); C) KEGG RCLASS 03212
(https://www.kegg.jp/entry/RC03212).

Figure 3.16. Atom mappings of MetaCyc reaction RXN-14940.
RXN-14940
(https://metacyc.org/META/NEW-IMAGE?object=RXN14940&&redirect=T).
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3.4

Discussion
Effective integration of compound and reaction from various sources is hard to

achieve due to incomplete and inconsistent atom-level and bond-level details, like R groups
and stereochemistry, across databases. First, we categorized compounds into specific and
generic compounds based on the presence of R groups. Meanwhile, metabolic reactions
were classified into specific and generic reactions according to the presence of generic
compounds. To overcome inconsistent atomistic characteristics, a set of relationships
between compounds were defined to both keep chemical details and conserve compound
pairs at various levels. According to the degree of consistency, compound pair relationships
are classified into three types: equivalence, generic-specific, and loose relationships. The
majority (around 60%) of specific compound pairs have loose relationships, confirming
the inconsistent issues in the databases to some extent. To our knowledge, no chemical
identifier can be used to directly harmonize generic compounds across databases. Here, we
further optimized a subgraph isomorphism detection algorithm to validate generic
compound pairs. We first made use of the metabolic reactions to discover possible generic
compound pairs. After validation, 2669 generic compound pairs remained. In addition, we
developed pragmatic methods to validate tautomers and compounds with linear and
circular representations. We discovered 45 compound pairs of compounds with the same
chemical formula but fundamentally different structures, for example linear versus
circularized chemical representations. In total, 15,704 harmonized compound pairs were
detected, which dwarfs our prior best published compound harmonization result of 8865
harmonized compound pairs and 5681 harmonized compound pairs identified by prior
identifiers and methods. Next, we mapped atom-resolved metabolic reactions across
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KEGG and MetaCyc via compound pairs and EC numbers. Reaction pairs were also
catalogued into hierarchical relationships in accordance with the classification of
compound pairs. About 3856 harmonized reaction pairs were detected, and 10% of them
can be missed by mismatched EC numbers (Figure 3.5 & 3.6), strongly suggesting that
curation of EC numbers is of great importance in reaction harmonization. A prior
systematic comparison of KEGG and MetaCyc had detected only 1961 shared reactions;
however, this comparison was published in 2013[125]. The BRaunschweig ENzyme
Database (BRENDA) indicates in a 2019 paper that 6115 reactions are harmonizable
between KEGG and MetaCyc[126]. However, BRENDA uses a combination of text
mining and prediction algorithms to build their database from primary literature, likely
making their harmonization results not as chemically specific as the results presented here
which directly analyzes molfiles provides by KEGG and MetaCyc.
Furthermore, we made use of the atom identifiers derived from our neighborhoodspecific graph coloring method to evaluate the consistency of atom mappings across
harmonized reactions. About 88% of reaction pairs have consistent atom mappings. For
the 12% of harmonized and comparable reactions that are inconsistent, we do not have
ground truth for determining which version of the reaction is correct. However, the fraction
of changed local atom color provides a uses metric for suggesting which version has higher
confidence. Additionally, given that these reaction descriptions represent reactions across
thousands of organisms, it is possible that both versions are correct in different organisms.
Additionally, we determined that both databases contain issues leading to inconsistency.
For example, atoms in some MetaCyc reactions are not mapped correctly. For KEGG, we
detected unsynchronized atom numbering in the older KEGG RPAIR representation,
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which is likely the reason that KEGG removed RPAIRS from their public version of the
database. In contrast, the KEGG RCLASS provides a concise RDM representation of
reaction atom mappings between a reaction-product compound pair, which appears highly
resistant to consistency errors. This resistance to consistency error is due to a decoupling
of the atom mappings from the specific atom order in the molfile representations. This
allows the molfile representations to be minorly updated without having to update the RDM
descriptions. However, there are also some issues with RDM descriptions. About 76
compound pairs cannot be parsed due to the incorrect description of reaction centers, and
parsed compound pairs can be unreasonable at reaction level. In addition, a few KEGG
RCLASS entries are computationally difficult to decipher due to a combinatorial issue
caused by the several factors: multiple reaction centers in a single reaction, symmetric
compounds, and reaction descriptions involving multistep reactions. This combination of
factors introduces a large number of possibilities with matching a list of RDM descriptions
to specific reaction center atoms. One way to prevent this combinatorial problem is to
represent multiple reaction center atoms with their associated difference atoms and match
atoms within a paired substructure representation instead of a list of RDM descriptions.
Figure 3.15 B illustrates this paired substructure representation for the KEGG RCLASS
RC02148. This kind of paired RDM substructure representation would allow the use of an
efficient subgraph isomorphism detection method to derive the atom mappings and could
be represented as a pair of molfiles along with a mapping of atoms between the two molfiles,
all stored within a single sdfile. Additionally, our compound harmonization method for
harmonizing changeable compound pairs would be useful for updating the paired RDM
substructures when the compound representations dramatically change.
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In addition, the methods we developed can be easily applied to integrate other
metabolic databases that provide molfile representations of compounds, facilitating the
expansion of the existing metabolic networks. Moreover, this hierarchical framework for
relating compounds and reactions is a possible first step towards creating a systematic
organization of all reaction descriptions at a desired chemical specificity to fit a given
application. Such a systematic organization of reaction descriptions would augment the
current Enzyme Commission number system and be useful to a wide range of possible
applications from metabolic modeling, metabolite and reaction prediction, and network
incorporation of newly discovered metabolites.
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CHAPTER 4. MOIETY MODELING FRAMEWORK FOR DERIVING MOIETY ABUNDANCES
FROM MASS SPECTROMETRY MEASURED ISOTOPOLOGUES

4.1

Introduction
Recent work indicates that many human diseases involve metabolic reprogramming

that disturbs normal physiology and causes serious tissue dysfunction[127]. Advances in
analytical technologies, especially mass spectroscopy (MS) and nuclear magnetic
resonance (NMR), have made metabolic analysis of human diseases a reality[48]. Stable
isotope tracing is a powerful technique that enables the tracing of individual atoms through
metabolic pathways. Stable isotope-resolved metabolomics (SIRM) uses advanced MS and
NMR instrumentation to analyze the fate of stable isotopes traced from enriched precursors
to metabolites, providing richer metabolomics datasets for metabolic flux analyses. NMR
can measure isotopomer-specific metabolite data, but is typically limited by sensitivity.
Often a single piece of NMR data only provides information on the presence of stable
isotopes in just a part of a metabolite, which represents a partial isotopomer. In some cases,
multiple partial isotopomer information can be interpreted in terms of a full isotopomer.
MS can measure isotopologue-specific data; however, an isotopologue represents a set of
mass-equivalent isotopomers. Comprehensive metabolic analysis often relies on MS
metabolic datasets or a combination of MS and NMR metabolic datasets. Even though
large amounts of metabolomics datasets have been generated recently, it is still a big
challenge to acquire meaningful biological interpretation from MS raw data, especially for
complex metabolites composed of multiple subunits or moieties.
To better interpret complex isotopologue profiles of large composite metabolites,
both quantitative analysis as well as detailed modeling are required. Several methods have
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been developed for quantitative flux analysis of specified pathways based on the stable
isotope incorporated data, like the elementary metabolite units (EMU) framework[56].
These methods rely heavily on well-curated metabolic networks to accomplish the
metabolic flux analysis. However, models of cellular metabolism, even for human, are far
from complete.
To deconvolute the relative isotope incorporation fluxes of complex metabolites, first
a plausible model of isotope incorporation should be built based on a relevant metabolic
network, which is often incomplete.

For example, the complex metabolite uridine

diphosphose N-acetyl-D-glucosamine (UDP-GlcNAc), illustrated in Figure 4.1 A, has four
distinct moieties in which 13C isotopes incorporate through a metabolic network from an
isotope labeling source like

13C-labeled

glucose. Based on the well-studied metabolic

pathways that trace from glucose to UDP-GlcNAc in human metabolism, the expected
(expert-derived) moiety model of

13C

isotope incorporation from

13 C-labeled

glucose is

illustrated in Figure 4.1 B, which includes 13C incorporation states for each moiety. For
example, the g6 state represents the incorporation of

13C
6

into the glucose moiety.

Furthermore, the sum of moiety states for a given moiety is equal to 1. With this moiety
model, a UDP-GlcNAc isotopologue profile can be deconvoluted into relative 13C isotope
incorporation into each UDP-GlcNAc moiety: glucose, ribose, uracil, and acetyl. The
deconvolution occurs by minimizing an objective function that compares calculated
isotopologues based on moiety isotope incorporation (enrichment) state parameters from
the model to the directly observed, experimentally-derived isotopologues.

From a

mathematics perspective, the minimization represents a highly non-linear inverse problem,
since the experimental intensities are compared to calculated values from nonlinear
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equations that use model parameters being optimized (Figure 4.1 B). With a time-series of
isotopologue profiles, relative isotope fluxes for each moiety can be derived and used for
the interpretation of isotope flux through specific metabolic pathways associated with each
moiety. However, when multiple models are plausible, development of a robust model
selection method is essential for successful isotopologue deconvolution, especially for nonmodel organisms. This basic approach to isotopologue deconvolution was demonstrated
in a prototype Perl program called GAIMS for the metabolite UDP-GlcNAc using a MS
isotopologue profile derived from a prostate cancer cell line[68]. This demonstration
derived relative 13C isotope fluxes for several converging biosynthetic pathways of UDPGlcNAc under non-steady-state conditions. This demonstration also inspired the
development of MAIMS, a software tool for metabolic tracer analysis[128], which further
validates the robustness of the moiety model deconvolution method. However, the MAIMS
software handles only 13C single isotope tracer data and does not address model selection,
which is crucial for addressing incomplete knowledge of cellular metabolic networks.
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Figure 4.1. Example complex metabolite UDP-GlcNAc and associated expert-derived
moiety model.
A) Major human metabolic pathways leading from glucose to the four moieties of UDPGlcNAc. B) The representative moiety model is based on the expected metabolic tracing
from 13C-labeled glucose to UDP-GlcNAc, with the exception of one carbon in the uracil
moiety that traces from carbon dioxide. The moiety states variables are identified by a
lowercase moiety letter followed by a number representing the 13C isotope content. The
moiety state variables (model parameters) are used to calculate specific components of the
relative isotopologue intensity.
In addition, the simultaneous use of multiple stable isotopes in SIRM experiments
can provide much more data than a single tracer. However, incorporation of multiple stable
isotopes also complicates the analysis of metabolite isotopologue profiles, which limits
most of the current isotope tracer experiments to a single tracer. The lack of data analysis
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tools greatly impedes the application of the multiple-labeled SIRM experiments. Therefore,
we have developed a new moiety modeling framework for deconvoluting MS isotopologue
profiles for both single and multiple-labeled SIRM MS datasets. This moiety modeling
framework not only solves the non-linear deconvolution problem, but also facilitates
selection of the optimal model describing the relative isotope fluxes for a specific
metabolite(s) from a set of plausible models.

4.2
4.2.1

Implementation
Overview of the moiety modeling framework
The workflow of the moiety modeling framework is composed of four major steps,

model and data representation, model (parameter) optimization, analysis of optimization
results, and model selection (Figure 4.2). For the model and data representation step, the
moiety_modeling package creates an internal representation of a moiety model from a
given JSONized moiety model description (see Figure 4.3). In this representation
illustrated by a unified modeling language (UML) class diagram in Figure 4.4, the package
first dissembles a complex metabolite into a list of moieties, i.e. metabolic subunits. Each
moiety may contain different number of labeling isotopes, representing the flow of isotope
from the labeling source to the moiety. A moiety with a specific number of labeled isotopes
is represented as an isotope enrichment state of the moiety (i.e. moiety state). As specified
in the JSONized model description, non-default mathematical relationships may exist
between moiety states, even from different moieties and/or molecules. Molecules, their
moieties, the possible moiety states, and relationships between moiety states work together
to represent a particular moiety model, and the proportion for each possible moiety state is
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an optimizable parameter of the model. Each mass spectrum’s worth of isotopologue data
is represented as a separate dataset, which holds the set of isotopologues associated with
each molecule. Typically, multiple mass spectra are included. Often each mass spectrum
represents a single time point in a time series experiment.

Figure 4.2. Workflow of the moiety modeling framework.
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Moiety
{
“name”: “ribose”,
“nickname”: “r”,
“ranking”: 1,
“maxIsotopeNum”: {“13C”: 5},
“isotopeStates”: [1, 129],
“states”: [ “13C0”, “13C2”, “13C3”, “13C5” ] ,
“py/object”: “moiety_modeling.model.Moiety”
}
Molecule
{
“name”: “UDP_GlcNAC”,
“moieties”: [{“py/id”: 13}, …],
“standardStates”: {“13C0”: [ [ “ribose[13C0]”, “glucose[13C0]”, “acetyl[13C0]”,
“uracil[13C0]”]], “13C10”: [ [“ribose[13C0]”, “glucose[13C6]”, “acetyl[13C2]”,
“uracil[13C2]”], [“ribose[13C5]”, “glucose[13C0]”, “acetyl[13C2]”,
“uracil[13C3]”], …], …},
“allStates”: [ “13C0”, “13C1”, “13C2”, “13C3”, “13C4”, “13C5”, “13C6”, “13C7”,
“13C8”,
“13C9”, “13C10”, “13C11”, “13C12”, “13C13”, “13C14”, “13C15”, “13C16”,
“13C17”],
“py/object”: “moiety_modeling.model.Molecule”
}
Relationship
{
“moiety”: {“py/id”: 13},
“moietyState”: “13C0”,
“varName”: “glucose[13C0]”,
“equivalentMoiety”: {“py/id”: 10},
“equivalentMoietyState”: “13C0”,
“equivalentVarName”: “ribose[13C0]”,
“multiplier”: 1,
“py/object”: “moiety_modeling.model.Relationship”
}

Figure 4.3. JSONized moiety model description.
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Figure 4.4. A unified modeling language (UML) class diagram of a Moiety Model.

The next major step, moiety model (parameter) optimization, involves deriving an
optimal set of model parameters, i.e. moiety state fractional abundances (𝑚𝑜𝑖𝑒𝑡𝑦_𝑠𝑡𝑎𝑡𝑒𝑗,𝑖
for moiety j and state i) that are used to calculate relative isotopologue abundances (Ix,calc
from Equation 1) that best match experimental isotopologue profiles (Ix,obs) as compared
by an objective function (see Table 4.1). In Equation 1, ica is a component of the
isotopologue intensity with an isotope content x. Figure 4.1B lists these isotopologue
components for each isotopologue based on the expert-derived moiety model.

𝐼𝑥,𝑐𝑎𝑙𝑐 = ∑𝑖𝑐𝑎 ∈𝐼𝐶𝑥 𝑖𝑐𝑎 ; 𝐼𝐶𝑥 = {𝑖𝑐𝑣 |𝑖𝑠𝑜𝑡𝑜𝑝𝑒_𝑐𝑜𝑛𝑡𝑒𝑛𝑡(𝑖𝑐𝑣 ) = 𝑥} ; 𝑖𝑐𝑣 = ∏𝑗 𝑚𝑜𝑖𝑒𝑡𝑦_𝑠𝑡𝑎𝑡𝑒𝑗,𝑣𝑗

Table 4.1. Different forms of objective function
Loss function
Absolute difference
Log difference
Square difference

(1)

Equation
Σ|Ix,obs – Ix,calc|
Σ|log(Ix,obs) – log(Ix,calc)|
Σ(Ix,obs – Ix,calc)2

The moiety_modeling package implements several optimization methods,
including a combined simulated annealing and genetic algorithm (SAGA) based on the
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‘Genetic Algorithm for Isotopologues in Metabolic Systems’ (GAIMS) Perl
implementation[68] , a truncated Newton algorithm (TNC)[130], a SLSQP algorithm
using Sequential Least Squares Programming[131], and a L-BFGS-B algorithm[132]. For
the latter three algorithms ‘TNC’, ‘SLSQP’, and ‘L-BFGS-B’, the moiety_modeling
package uses the implementation from the scipy.optimize Python module. In addition, we
have the option to optimize the datasets together or separately.
The third major step involves the analysis of the results from the model
optimization. The moiety_modeling package provides facilities for generating summative
statistics and graphical visualizations for a set of optimizations performed on one or more
moiety models. The final major step, model selection, tries to find the model that best fits
the experimental isotopologue profiles from a set of provided moiety models that have been
optimized in step two. Several forms of the Akaike information criterion (AIC)[133] and
Bayesian information criterion (BIC)[134] are used as the estimator of the relative quality
of moiety models for the set of isotopologue data.
4.2.2

The moiety_modeling Python package implementation
As shown in Figure 4.5, the moiety_modeling Python package consists of several

modules: ‘model.py’, ‘modeling.py’, ‘analysis.py’, and ‘cli.py’. The ‘model.py’ module
contains class definitions for the basic elements in the moiety model. It is composed of
‘Moiety’, ‘Relationship’, ‘Molecule’ and ‘Model’ classes. The ‘Moiety’ object represents
a specific moiety, the labeling isotopes present in the moiety, and their corresponding states
within the moiety. The ‘Relationship’ class describes the non-default mathematical
dependencies between moiety states, where the default dependency for a given moiety is
that the sum of its states is equal to 1 (see Figure 1B for example default relationships). A
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‘Molecule’ object represents an individual metabolite made up of a list of ‘Moiety’ objects.
The ‘Model’ class simulates the flow of isotope from labeling sources into each moiety of
specific metabolites, which is initialized by lists of ‘Moiety’ objects, ‘Molecule’ objects,
and ‘Relationship’ objects. A moiety model is generated and stored in a JSONized
representation using the jsonpickle Python package[135]. This JSONized representation
(see Supplementary Data 4.1), stored in a file, is then used as the input file for later model
optimizations. The ‘modeling.py’ module is responsible for model optimization. It is
composed of the ‘Dataset’ class, several model optimization classes, and the
‘OptimizationManager’ class. The ‘Dataset’ class organizes a single MS isotopologue
profile dataset into a dictionary-based data structure. ‘Dataset’ objects are stored in a
JSONized representation (see Supplementary Data 4.2) and used as the input for later
model optimizations. Currently, no relationship between Dataset objects like a timedependence is captured. In the abstract ModelOptimization class, we included several
different objective functions (see Table 4.1). In addition, there are four specific model
optimization classes in the ‘modeling’ module that utilize different optimization methods
and

approaches

for

combining

datasets.

The

‘SAGAoptimization’

and

‘SAGAseparateOptimization’ classes use the SAGA-optimize Python package described
in the next section for either combined optimization of model parameters across all datasets
or separate optimizations of model parameters for each dataset. ‘ScipyOptimization’ and
‘ScipySeparateOptimization’ classes make use of optimization methods (‘TNC’, ‘SLSQP’,
and ‘L-BFGS-B’) in the scipy.optimize module to conduct optimizations in either a
combined or separate manner. The ‘OptimizationManager’ class is responsible for the
management of the optimization process based on the input optimization parameters. The
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results for a model optimization are stored in a JSONized representation (see
Supplementary Data 4.3) for further analysis. A text file is used to store the filepaths to all
of the optimized models with certain optimization parameters. The filepath file is then used
as the input for the ‘analysis.py’ module. The ‘analysis.py’ module has five classes:
‘ResultsAnalysis’, ‘ModelRank’, ‘ComparisonTable’, ‘PlotMoietyDistribution’ and
‘PlotIsotopologueIntensity’. The ‘ResultsAnalysis’ class is responsible for generating
standard statistics from the results for a set of optimizations for a given model. The mean,
standard deviation, minimum, and maximum value of each model parameter are calculated
from a set of model optimizations performed on the same model. The calculated
isotopologue intensities and their statistics based on the sets of optimized parameters are
also generated. Furthermore, several quality estimators of each model, including different
forms of the ‘AIC’ (Table 4.2), are computed for model selection. The AIC tends to select
the model that has too many parameters when the sample size is small, leading to
overfitting. The sample size corrected AIC (AICc) was developed to address this
overfitting problem[136]. The Bayesian information criterion (BIC) is another commonly
used criterion for model selection[137]. The ‘ResultsAnalysis’ objects with results for each
model are stored in a JSONize representation (see Supplementary Data 4.4) for further
analysis, along with a text report for readability. Also, an analysis filepath file containing
the filepaths to the analysis JSON files of all models with the same optimization parameters
is created. Next, the ‘ModelRank’ class object uses this analysis filepath file to compare
and select the model that best reflects the observed isotopologue profile. The
‘ComparisonTable’ class compares the model selection results with different optimization
parameters. The ‘PlotMoietyDistribution’ class and ‘PlotIsotopologueIntensity’ class are
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responsible for the visualization of the optimization results for a set of optimizations
performed on a single model. The ‘cli.py’ module provides the command-line interface to
perform model optimization, model optimization analysis, and model selection, which is
implemented with the ‘docopt’ Python library[78].
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Figure 4.5. Organization of the moiety_modeling package represented with UML
diagrams.
A) UML package diagram of the moiety_modeling Python library; B) Subpackage
dependencies diagram; C) UML class diagram of the ‘modeling.py’ module with
dependency relationships; D) UML class diagram of the ‘analysis.py’ module, which
contains a set of classes with no relationships.
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Table 4.2. Different forms of a model selection estimator
Selection Criterion
Equation
Akaike Information Criterion (AIC)
2k + nln(RSS/n)
Sample size corrected AIC (AICc)
AIC + (2𝑘 2 + 2k)/(n − k − 1)
Bayesian Information Criterion (BIC)
nln(RSS/n) + kln(n)
k is the number of parameters.
n is the number of data points.
RSS is the residual sum of squares: RSS = ∑𝑛𝑖=1(𝐼𝑜𝑏𝑠 − 𝐼𝑐𝑎𝑙𝑐 )2.

4.2.3

SAGA-optimize Python package implementation
The SAGA-optimize Python package is a novel type of combined simulated

annealing and genetic algorithm[68] used to find the optimal solutions to a set of
parameters based on the minimization of a given energy (objective) function calculated
using the set of parameters. In this context, the energy function represents a comparison
of calculated and experimentally-observed isotopologue relative intensities, with the
calculated intensities based on the moiety model parameters being optimized. As shown in
Figure 4.6, it is composed of ‘ElementDescription’, ‘Guess’, ‘Population’ and ‘SAGA’
classes. An ‘ElementDescription’ object describes an individual parameter of the moiety
model. In the expert derived moiety model (Figure 4.1B), the g6 model parameter would
be represented by a single ‘ElementDescription’ object. The ‘ElementDescription’ object
is bound by a range and several mutation methods are available to change the value of the
‘ElementDescription’ object. A ‘Guess’ object contains lists of all the parameters
(‘ElementDescription’ objects) and their corresponding values for a particular moiety
model. In addition, it also stores the energy calculated based on this set of parameters. A
‘Population’ object contains information of a list of ‘ElementDescription’ objects, a list of
‘Guess’ objects, the range of each ‘ElementDescription’ among all the ‘Guess’ objects, the
highest and lowest energy for the list of ‘Guess’ objects, and the best ‘Guess’ object. The
‘ElementDescription’, ‘Guess’ and ‘Population’ classes are the building blocks of the
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‘SAGA’ class, which is the main class that provides the interface for optimization.
Furthermore, several distinct crossover functions are available for creating new Guess
objects from the cross-over of two other Guess objects.

Figure 4.6. ‘SAGA-optimize’ package represented with a UML class diagram with
dependencies.
4.3
4.3.1

Results
The package interface
The moiety_modeling package can be used in two main ways: (i) as a library within

Python scripts for accessing and manipulating moiety models and isotopologue datasets
stored in JSON files, or (ii) as a command-line tool to perform model optimization, model
analysis, and model selection.
To use the moiety_modeling package as a library within Python scripts, it should
be imported with a Python program or an interactive interpreter interface. Next, ‘Moiety’,
‘Relationship’ and ‘Molecule’ objects can be created to construct a moiety model. ‘Dataset’
objects are also built with the moiety_modeling package. Table 4.3 summarizes common
patterns for using moiety_modeling package as a library in construction of a moiety model
and related datasets.
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The moiety_modeling package also provides a simple command-line interface to
perform model optimization, selection, and visualization. Figure 4.7 shows version 1.0 of
the command-line interface, and Table 4.4 summarizes common pattern for using
moiety_modeling as a command-line tool. The common patterns for using SAGA-optimize
as a library are shown in Table 4.5.
Table 4.3. Common creation patterns for the moiety_modeling library
Entity
Example
Moiety
Relationship
Molecule
Model
Dataset

glucose = moiety_modeling.Moiety(‘glucose’, {‘13C’: 6}, isotopeStates={‘13C’: [1, 3, 5]}, nickname= ‘g’)
acetyl = moiety_modeling.Moiety(‘acetyl’, {‘13C’: 2}, isotopeStates={‘13C’: [0, 1, 2]}, nickname= ‘a’)
uracil = moiety_modeling.Moiety(‘uracil’, {‘13C’: 4}, isotopeStates={‘13C’: [1, 2, 4]}, nickname= ‘u’)
ribose = moiety_modeling.Moiety(‘ribose’, {‘13C’: 5}, isotopeStates={‘13C’: [0, 3, 5]}, nickname= ‘r’)
relationship = moiety_modeling.Relationship(glucose, ‘13C0’, acetyl, ‘13C2’, ‘*’, 2)
UDP-GlcNAc = moiety_modeling.Molecule(‘UDP-GlcNAc’, [glucose, uracil, acetyl, ribose])
model1 = moiety_modeling.Model(‘model1’, [glucose, uracil, acetyl, ribose], [UDP_GlcNAc], [relationship])
dataset = moiety_modeling.Dataset(‘12h’, ‘UDP_GlcNAc’: [{‘labelingIsotopes’:’13C_0’, ‘height’: 0.0175,
‘heightSE’: 0 }, {‘labelingIsotopes’:’13C_1’, ‘height’: 0.0075, ‘heightSE’: 0 }, …] )

The moiety_modeling command-line interface.
Usage:
moiety_modeling –h | --help
moiety_modeling --version
moiety_modeling modeling [--combinedData=<combined_jsonfile>] [--models=<models_jsonfile>] [-datasets=<datasets_jsonfile>] [--optimizations=<optimizations_jsonfile>] [--working=<working_dir>] [-repetition=<optim_count>] [--split] [--force] [--multiprocess] [--energyFunction=<function>] [--printOptimizationScripts]
moiety_modeling analyze optimization --a <optimzationPaths_txtfile> [--working=<working_dir]
moiety_modeling analyze optimization --s <optimzationResults_jsonfile> [--working=<working_dir]
moiety_modeling analyze rank <analysisPaths_txtfile> [--working=<working_dir>] [--rankCriteria=<rankCriteria>]
moiety_modeling analyze table <rankPaths_txtfile> [--working=<working_dir>]
moiety_modeling plot moiety <analysisResults_jsonfile> [--working=<working_dir>]
moiety_modeling plot isotopologue <analysisResults_jsonfile> [--working=<working_dir>]
Options:
-h, --help
Show this screen.
--version
Show version.
-combinedData
JSON description file of the combined data (eg: models, datasets,
optimization settings)
--models=<models_jsonfile>
JSON description file of the moiety models.
--datasets=<datasets_jsonfile>
JSON description file of the datasets.
--optimizaitons=<optimizaitons_jsonfile>
JSON description file of the optimization setting.
--working=<working_dir>
Alternative path to save the results.
--repetition=<optim_count>
The number of optimization repetitions to perform [default: 100].
--split
To split the datasets or not.
--force
To force optimization process if error occurs.
--mulitprocess
To perform with multiprocessing or not.
--printOptimizationScripts
To print the optimization script or not.
--a
To analyze a bunch of optimization results together with the path
file.
--s
To analyze a single moiety model optimization results.
--energyFunction=<function>
The energy function for optimization [default: logDifference].
--optimzationSetting=<optimizationSetting> The optimization setting of the moiety modeling optimization.
--rankCriteria=<rankCriteria>
The criteria for model ranking [default: AIC]

Figure 4.7. The ‘moiety_modeling’ package command line interface.
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Table 4.4. Common patters for using the moiety_modeling as a command-line tool
Command
Description
Example
modeling

Perform model
optimization

% python3 –m moiety_modeling modeling -models=models.json --datasets=dataset.json -optimizations=optimization_settings.json

analyze

Analyze the optimization
results

% python3 –m moiety_modeling analyze optimizations --a
optimizationPaths.txt

plot

Plot the distribution of
calculated moiety
modeling parameters.

% python3 –m moiety_modeling plot moiety
analysisResults.json

Table 4.5. Common patterns for using ‘SAGA’ module as a library.
Usage
Example
SAGA

saga = SAGA.SAGA(stepNumber=100, temperature=10, startTemperature=0.5,
alpha=1, energyfunction=targertedEnergyFunction)
saga.addElmentDescriptions(SAGA.ElementDecription(low=0, high=1))

Population

population = saga.optimize()

Guess

bestGuess = population.bestGuess

4.3.2

Dataset and model
We used the timecourse (34h, 48h, and 72h) of

13C

isotopologue data for UDP-

GlcNAc generated from [U-13C]-glucose in human prostate cancer LnCaP-LN3 cells to
evaluate the robustness of the moiety modeling framework. An expert-derived moiety
model of UDP-GlcNAc (6_G1R1A1U3) was created based on known human biochemical
pathways (Figure 4.1A) and corroborated by NMR data. Also, 40 hypothetical moiety
models of the isotopic flow into UDP-GlcNAc were crafted as simple perturbations of the
original expert-derived model. These perturbations include the inclusion of different and/or
additional moiety states and non-default moiety state relationships (e.g. g6 = r5). For
example, model 7_G2R1A1U3_g5 includes an extra

13C
5

g5 glucose moiety state for a

total of 7 independent model parameters, 2 for glucose, 1 for ribose, 1 for acetyl, and 3 for
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uracil. We tested whether the expert-derived moiety model could be selected from all the
other models.
4.3.3

Model optimization and selection
The incorporation of 13C from [U-13C]-glucose into UDP-GlcNAc leads to a total

of 17 isotopologues plus one due to 13C natural abundance from carbon dioxide (I0, …, I17).
We applied the moiety modeling framework to the observed UDP-GlcNAc isotopologue
data with each built model to test whether the expert-derived moiety model could be
selected above the other models. We used the SAGA optimization method with a log
difference objective function (see Table 4.1). The optimization was repeated 100 times for
each model. These analyses were performed on a desktop computer with i7-6850K CPU
(6 core with HT), 64GB RAM and 512GB SSD. On this hardware, the analyses for all 40
models took roughly 3 hours of total execution time. The results are list in the Table 4.6.
From these results, we can see that the expert-derived moiety model can be selected
successfully among all the moiety models using the AICc (see Table 4.2), which
demonstrates the robustness of the moiety modeling framework. Model selection criteria
like the AICc help to address model overfitting; however, the use of a log difference
objective function with multiple time points of data in the form of separate sets of observed
isotopologues makes the model selection very robust against most of the model
overfitting[68]. We also compared the optimization results generated by the moietymodeling package to results generated by GAIMS (see Supplementary Table 4.1 & 4.2,
Supplementary Figure 4.1). For this comparison, an absolute difference objective function
was used with the moiety-modeling package to match the objective function available in
the GAIMS software. Also, there are some small differences in the implementation of
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optimization method between the two software packages. The SAGA-optimize package
implements a true simulated annealing, while GAIMS implements a modified annealing
with steepest decent qualities. Also, both optimization methods are stochastic as
demonstrated by replicate moiety-modeling analyses shown in Supplementary Table 4.3.
Therefore, the results are not identical; however, they are reasonably comparable. But
neither method is able to select the expert-derived model with an AICc model selection
method, due to issues of overfitting with the absolute difference objective function.
Table 4.6. Model selection results of UDP-GlcNAc isotopologue data
Modela
Estimator (AICc)
6_G1R1A1U3 (expert-derived model)
-229.2918
6_G1R1A1U3_r4
-227.5208
6_G1R1A1U3_u4
-225.0006
6_G0R2A1U3_g3r2r3_g6r5
-223.1633
6_G1R1A1U3_g5
-215.9565
7_G1R2A1U3_r1
-212.4727
7_G2R1A1U3_g1
-212.1217
7_G1R2A1U3_r3
-210.9640
7_G1R1A2U3
-210.0952
7_G2R1A1U3_g5
-208.1346
7_G1R2A1U3_g3r2r3
-207.6523
7_G1R2A1U3_r2
-207.4187
7_G2R1A1U3_g4
-206.6430
7_G2R1A1U3_g2
-206.5609
7_G0R2A2U3_g3r2r3_g6r5
-205.0569
7_G2R1A1U3_g3
-204.8797
7_G0R3A1U3_g3r2r3_g6r5_g5r4
-204.2729
7_G1R1A1U4
-203.3710
7_G1R2A1U3_r4
-202.6782
6_G1R1A1U3_a1
-199.5560
8_G2R1A2U3_g1
-195.9713
7_G1R1A1U3C1
-195.5788
8_G1R2A2U3_r1
-195.4893
7_G0R3A1U3_g3r2r3_g6r5_r4
-192.4980
8_G1R2A2U3_r2r3
-187.3342
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8_G1R2A2U3_r3
8_G2R1A2U3_g5
8_G1R2A2U3_r2
8_G2R1A2U3_g2
8_G2R1A2U3_g4
8_G1R2A2U3_g3r2r3
8_G1R2A2U3_g3r2r3_g6r5_g5
8_G2R1A2U3_g3
8_G1R2A2U3_r4
8_G1R1A2U3C1
9_G2R2A2U3_r2r3_g1
9_G2R2A2U3_r2r3_g2
9_G2R2A2U3_r2r3_g3
9_G2R2A2U3_r2r3_g6r5_g3_g5
9_G2R2A2U3_r2r3_g4
9_G2R2A2U3_r2r3_g5

-186.8810
-186.2693
-186.2562
-185.6112
-184.9444
-184.2929
-183.2154
-183.1467
-182.1334
-177.5013
-170.3323
-161.5770
-160.7823
-160.6917
-160.4500
-158.8733

Optimization settings: method = ’SAGA’, SAGA_parameters = {‘stepNumber’: 100000, ‘temperatureStepSize’: 100,
‘alpha’: 1, ‘crossoverRate’: 0.05, ‘mutationRate’: 3, ‘populationSize’: 20, ‘startTemperature’: 0.5}, repetition=100,
split, objective function=log difference.
aThe first number in the model name is the total number of free model parameters followed by the number of free
parameters for each moiety and perturbations from the expert-derived model.

4.3.4

Generation of simulated single-tracer and multi-tracer datasets
In addition, we generated simulated single tracer and multi-tracer datasets to test,

compare, and evaluate multi-tracer optimization functionality. First, we created a set of
rounded moiety state values for the single-tracer expert derived model roughly based on
the optimized model state values derived from the experimental UDP-GlcNAc 48h dataset
(Table 4.7).
Table 4.7. Single-tracer 13C moiety states and values for UDP-GlcNAc biosynthesis
Moiety states
Moiety value
Moiety states
Moiety value
glucose[13C_0]
0.1
ribose[13C_5]
0.9
glucose[13C_6]
0.9
uracil[13C_0]
0.2
acetyl[13C_0]
0.7
uracil[13C_1]
0.2
acetyl[13C_2]
0.3
uracil[13C_2]
0.5
ribose[13C_0]
0.1
uracil[13C_3]
0.1
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We then used 13C and 18O labeled glucose (13C6H1218O6) as a hypothetical isotope
labeling source for UDP-GlcNAc biosynthesis. Following the expert derived model and
with the aid of atom-mapping information of relevant human biochemical reactions from
MetaCyc[78], we traced the incorporation of oxygen and carbon atoms from glucose to
each moiety to derived a multi-tracer model. For glucose, acetyl and ribose, oxygen atoms
incorporated into the moiety with their directly bonded carbon atom. However, during the
biosynthesis of uracil, some 18O-13C bonds are sometimes broken, creating a more varied
set of moiety states. Next, we derived rounded multi-tracer moiety state values that are
equivalent to the rounded single-tracer values (Table 4.8).
Table 4.8. Multi-tracer 13C/18O moiety states and values for UDP-GlcNAc biosynthesis
Moiety states
Moiety value
Moiety states
Moiety value
glucose[13C_0.18O_0]
0.1
uracil[13C_0.18O_0]
0.2
glucose[13C_6.18O_5]
0.9
uracil[13C_1.18O_0]
0.2
acetyl[13C_0.18O_0]
0.7
uracil[13C_2.18O_0]
0.25
acetyl[13C_2.18O_1]
0.3
uracil[13C_2.18O_1]
0.25
ribose[13C_0.18O_0]
0.1
uracil[13C_3.18O_0]
0.05
ribose[13C_5.18O_4]
0.9
uracil[13C_3.18O_1]
0.05

Next, we generated the base single-tracer and multi-tracer simulated datasets by
calculating the set of relative isotopologue intensity values using Equation 1 with the
respective moiety state values. Finally, we created simulated datasets with added normally
distributed error that is subsequently thresholded to zero based on a minimum hypothetical
detection limit (0.005) and then renormalized to a sum of 1. We generated three sets of
100 simulated datasets for both single and multi-tracer models by adding error from a
normal distribution with increasing standard deviations of 0.001, 0.01 and 0.1. We then
estimated the effects of error propagation by calculating the average sum of isotopologues
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across 100 simulated datasets after error addition and thresholding, but before
renormalization (Table 4.9).
Table 4.9. Multi-tracer 13C/18O moiety states and values for UDP-GlcNAc biosynthesis
Average Sum of Isotopologues
σ of Added Error
Single-tracer
Multi-tracer
0.1
1.50
9.97
0.01
1.02
1.73
0.001
0.99
0.98

Based on this calculation, the single-tracer datasets and the multi-tracer datasets
have comparable levels of propagated error when normal error with a 0.001σ is added.
However, this quickly deviates with larger amounts of additive error as shown by singletracer datasets with a 0.1σ added normal error having slightly less propagated error than
the multi-tracer datasets with a 0.01σ added normal error. The multi-tracer datasets with a
σ=0.1 added normal error are practically useless due to the level of propagated error being
roughly nine (i.e. 9.97 - 1.00 = 8.97 ≈ 9) times the original signal on average. Using
histograms of simulated intensities for the largest respective isotopologue in both the
single-tracer and multi-tracer simulated datasets, Figure 4.8 illustrates these error
propagation effects due to thresholding and renormalization. It is clear from this figure the
loss of intensity information in the multi-tracer simulated dataset with σ=0.1 added normal
error.
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Figure 4.8. Histograms of simulated intensities for the largest representative isotopologue.
4.3.5

Model optimization of simulated multi-tracer and single-tracer datasets and
comparison of results
For each simulated dataset consisting of a single time point, the respective model

was optimized 100 times (i.e. in 100 separate repetitions), each using 5000 steps of SAGA
with an absolute objective function. This generated 10,000 separate optimizations for each
set of simulated datasets at a given added level of error. Using histograms, Figure 4.9
visualizes the distribution for the acetyl and uracil moiety state values for the multi-tracer
dataset with 0.01σ added normal error and for the single-tracer datasets with σ=0.1 and
σ=0.01 added normal error. The full set of histograms are in Supplementary Figure 4.2 for
the multi-tracer results and Supplementary Figure 4.3 for the single tracer results. When
comparing multi-tracer and single-tracer experiments with equivalent added normal error
(σ=0.01), the propagated error leads to wider variances in the multi-tracer moiety state
values and some additional skewness of their distributions. However, some of the singletracer moiety state value distributions are bimodal. When comparing multi-tracer and
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single-tracer experiments with comparable propagated error levels, the multimodality in
the single-tracer distributions become very pronounced, especially in the acetyl moiety
states.

Figure 4.9. Histograms of the acetyl and uracil optimized moiety state values derived from
simulated datasets.
4.4
4.4.1

Discussion
Advantage of JSONized representation for MS isotopologue data and analysis
results
JavaScript object notation (JSON)[138] is an open-standard file format using

human-readable text to collect data in pair-value and array structures, widely used by
different programming language. Complex Python objects, like ‘Moiety’ and ‘Molecule’
objects mentioned above, can be serialized to JSON format with the jsonpickle Python
library. The moiety model and dataset constructed with moiety_modeling package as well
as optimization parameters are the input files for the moiety modeling, all of which are
saved in JSON format using jsonpickle (see Supplementary Data 4.1, 4.2 and 4.5). The use
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of JSON format makes the moiety modeling framework easily accessible to other
programming languages and naturally extendible. In addition, the optimization and
analysis results are also stored in a JSON file (see Supplementary Data 4.3 & 4.4).
4.4.2

Advantages and limitations of the SAGA-optimize and moiety-modeling
packages
The SAGA-optimize package provides certain advantages to the model

optimization versus the other optimization methods from scipy and even a similar
implementation in GAIMS. The level and steepness of optimization can be precisely tuned
with the specification of the annealing length and schedule. Also, this novel
implementation of a combined simulated annealing and genetic algorithm incorporates the
annealing processing directly into the mutation step itself, attenuating the level of mutation
as the annealing temperature drops. The moiety-modeling package provides a range of
objective functions and can split each independent set of isotopologues into individual
moiety model optimizations, which neither the GAIMS nor MAIMS packages can do.
Moreover, both the SAGA-optimize and moiety-modeling packages have multiprocessing
facilities that enable an efficient utilization of all CPU cores. As demonstrated in the Table
4.6 results, the combination of advantages allows the moiety-modeling package to optimize
and accurately select the expert-derived model in roughly one tenth of the execution time
of the original GAIMS package, i.e. with 100,000 steps of optimization in moiety-modeling
versus 1,000,000 steps in GAIMS. Also, both the SAGA-optimize and moiety-modeling
packages contain over 2200 lines of code implemented in major version 3 of the Python
language with a fully object-oriented design and Pythonic style. Every module, class,
method, and function have documentation strings (docstrings) written in the
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reStructuredText markup language. Variables, data members, methods, functions, and
classes have descriptive names as demonstrated in Figures 4.4, 4.5, and 4.6.
Documentation is automatically generated using the Sphinx Python Document Generator
and made available on ReadTheDocs.

This documentation includes a user guide,

installation instructions, tutorial, and application programming interface (API) reference.
Both packages are available on GitHub, utilize Travis CI for continuous integration, and
are distributed via the Python Package Index. Code coverage from unit testing is above 65%
for moiety-modeling and above 73% for SAGA-optimize. These packages enable
researchers to perform moiety model isotopologue deconvolution using JSON
representations of moiety models, datasets, and optimization method selection and settings
provided by the user. At this time, the moiety-modeling package has no facilities for
automatic moiety model generation.
4.4.3

Difficulty in generating simulated datasets and comparing multi-tracer to singletracer moiety modeling results
The generation of realistic simulated biophysical datasets is always a non-trivial

task[138]. Even the addition of normal additive error can create non-intuitive propagation
of error, especially through inverse problems[139]. This is illustrated in Table 4.8 and
Figure 4.8, where thresholding creates a positive bias in accumulated error and the
renormalization creates a proportional-like error component from this positive
accumulated error. The thresholding is required to keep the simulated data within the
physical boundaries of the analytical detection, i.e. all non-negative values.

The

renormalization keeps the simulated data within mathematical boundaries, i.e. the sum of
the isotopologue values is equal to 1. Neither step can be avoided with the inclusion of

98

normal additive error. This created error propagation problem is quite dramatic for the
simulated multi-tracer datasets, because there are 324 possible isotopologues in the multitracer datasets as compared to only 18 isotopologues in the single-tracer datasets. This
problem simply increases in magnitude with the number of isotopologues present in a
dataset. With a σ=0.1 added normal error, the isotopologue intensity information is
effectively lost for the multi-tracer datasets (see Figure 4.8) and these datasets become
effectively unusable (see Supplementary Figure 4.2). However, the lower additive error
datasets are usable and illustrate the power of multi-tracer datasets to reduce multimodality
in optimized moiety state values as compared to the single-tracer datasets.

4.5

Conclusions
Here, we present a moiety modeling framework for the deconvolution of metabolite

isotopologue profiles using moiety models along with the analysis and selection of the best
moiety model(s) based on the experimental data. This framework can analyze datasets
involving single and multiple isotope tracers as demonstrated on simulated datasets for
multiple tracer models and both simulated and experimental datasets on single tracer
models. With a 13C-labeled UDP-GlcNAc isotopologue dataset, we further demonstrate the
robust performance of the moiety modeling framework for model selection on real
experimental datasets. The selection of correct moiety models is required for generating
deconvolution results that can be accurately interpreted in terms of relative metabolic flux.
Furthermore, the JSON formats of moiety model, isotopologue data, and optimization
results facilitate the inclusion of these tools in data analysis pipelines. Future work will
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explore the data quality requirements of model selection and validation of multiple isotope
tracing model optimization and selection.
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CHAPTER 5. ROBUST MOIETY MODEL SELECTION USING MASS SPECTROMETRY
MEASURED ISOTOPOLOGUES

5.1

Introduction
While the first observations of metabolic alterations in cancer were made about a

century ago[140], metabolomics is a relatively new field of ‘omics’ technology aiming to
systematically characterize metabolites being created and/or utilized in cells, tissues,
organisms, and ecosystems[141]. This combined consumption and biosynthesis of
metabolites can be represented as flux through specific metabolic paths within cellular
metabolism, reflecting specific physiological and pathological states in biomedically useful
detail and in ways that are distinct and often more sensitive than other omics methods. It is
increasingly recognized that metabolomics biomarkers have great utility in characterizing
and monitoring diseases with significant metabolic reprogramming like cancer[127].
Therefore, better regulatory understanding of specific metabolic flux phenotypes of
metabolic diseases will aid in developing new therapeutic strategies.
Stable isotope resolved metabolomics (SIRM) experiments utilize stable isotopes
from a labeling source to isotopically enrich detected metabolite analytical features,
providing more complex but data-rich metabolomics datasets for metabolic flux analysis.
Advances in mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR)
greatly contribute to the generation of high-quality SIRM datasets[48]. However,
computational methods are required to gain biologically meaningful interpretation from
such complex datasets, especially in terms of metabolic flux through specific metabolic
paths in cellular metabolism. Most current metabolic flux analysis methods heavily depend
on a predetermined metabolic network and are mostly focused on the analysis of 13C tracer
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experiments[53, 56, 65, 142]. However, large numbers of ‘unknown’ metabolites in the
metabolomics datasets strongly indicate that current metabolic network are far from
complete, especially for secondary metabolism and central metabolism of non-model
organisms[129, 143, 144]. Without an accurate and reasonably-defined metabolic network,
it is challenging to conduct meaningful metabolic flux analyses. Even worse, assuming a
metabolic model is accurate compromises the scientific rigor of the metabolic modeling
and can lead to misinterpretation of results[139].
Our newly developed moiety deconvolution package called moiety_modeling is a
novel method for analyzing time series SIRM MS isotopologue profiles that can involve
single or multiple isotope tracers[69]. This package integrates facilities for moiety (i.e.
biochemical functional group) model and data representation, model (parameter)
optimization, analysis of optimization results, and model selection under a single moiety
modeling framework. A typical data analysis workflow for this moiety modeling
framework is shown in Figure 5.1. Moiety modeling deconvolutes isotopologue intensity
data of a metabolite into pseudo-isotopomers based on a given moiety description of the
metabolite. Moiety modeling is an early step in certain metabolic flux analysis approaches
that can allow the comparison of different moiety models for model selection. First,
plausible and hypothetical moiety models of an interesting metabolite are provided by a
user based on a relevant metabolic network. After the optimization of each moiety model
during isotopologue deconvolution, the optimal model can be selected based on the
optimized results of model parameters, which can be directly used for downstream
metabolic flux analysis and interpretation.
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Figure 5.1. Workflow for Moiety Modeling.
In this chapter, we use this moiety modeling framework to investigate the effects of
the optimization method, optimizing degree, objective function and selection criterion on
model selection to identify modeling criteria that promote robust model selection. To our
knowledge, this is the first attempt to investigate how all of these factors can affect model
selection in metabolic modeling.

5.2
5.2.1

Materials and Methods
UDP-GlcNAc time course MS isotopologue datasets
Two UDP-GlcNAc time course MS isotopologue datasets were used to test the

robustness of model selection mechanism. The first is a direct infusion Fourier transform
MS (FTMS) UDPGlcNAc

13C

isotopologue dataset derived from LnCaP-LN3 human

prostate cancer cells with [U-13C]-glucose as isotope labeling source and collected on an
Advion Nanomate nanoelectrospray inline connected to a Thermo 7T LTQ Fourier
transform ion cyclotron resonance MS (FT-ICR-MS). This dataset includes 3 time points:
34h, 48h, and 72h[68]. The second is a liquid chromatography-MS (LC-MS) UDP-GlcNAc
13C isotopologue

dataset derived from human umbilical vein endothelial cells with [U-13C]-

glucose as the isotope labeling source and collected on a ThermoFisher Dionex UltiMate
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3000 LC System in-line connected to a ThermoFisher Q-Exactive Orbitrap MS. This
dataset has 5 time points: 0h, 6h, 12h, 24h and 36h[128].
5.2.2

Objective functions
We used four distinct forms of the objective function (Table 5.1) that compares the

observed isotopologues and corresponding calculated isotopologues derived from model
parameters obtained from model optimization. The first is a summation of absolute
differences between observed and calculated isotopologues, which is generally expected to
work well with data where the dominant type of error is additive. The second is a
summation of the absolute differences between the log of observed and calculated
isotopologues, which is generally expected to work well with data where the dominant type
of error is proportional. The third is a summation of square of differences between
observed and calculated isotopologues. The fourth one tries to mimic the effect of model
selection criteria.
Table 5.1. Objective functions.
Objective function
Absolute difference
Absolute difference of logs
Square difference
Difference of AIC

Equation
Σ|In,obs – In,calc|
Σ|log(In,obs) – log(In,calc)|
Σ(In,obs – In,calc)2
2k + nln(RSS/n)

k is the number of parameters.
n is the number of data points.
RSS is the residual sum of squares: RSS = ∑𝑛𝑖=1(𝐼𝑜𝑏𝑠 − 𝐼𝑐𝑎𝑙𝑐 )2.

5.2.3

Optimization methods
From a mathematics perspective, model optimization is actually a non-linear

inverse problem. Several different optimization methods were used to solve this problem,
including the SAGA-optimize method[68], and three other optimization methods
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(‘TNC’[130], ‘SLSQP’[131], and ‘L-BFGS-B’[132]) available in the scipy.optimize
Python module. The SAGA-optimize is a combination of simulated annealing (SA) and
genetic algorithm (GA) that gains advantages of both SA and GA, making it able to produce
better quality results in small amount of time. The ‘TNC’ method is designed for
optimizing non-linear functions with large numbers of independent variables[130]. The
SLSQP method uses Sequential Least Squares Programming, which is an iterative method
for constrained nonlinear optimization[131]. ‘L-BFGS-B’ is a limited-memory algorithm
for solving large nonlinear optimization problems subject to simple bounds on the
variables[132].
5.2.4

Model Selection Estimators
We used three different quality estimators (Table 5.2) in model selection: the

Akaike Information Criterion (AIC)[133], the sample size corrected Akaike Information
Criterion (AICc)[136], and the Bayesian Information Criterion (BIC)[134]. The Akaike
information criterion (AIC) is biased to select models with more parameters when the
sample size is small, which can lead to overfitting[133]. The sample size corrected AIC
(AICc) was developed to handle this bias and prevent overfitting[136]. The Bayesian
information criterion (BIC) is another criterion commonly used in model selection[134].
Table 5.2. Model selection estimators.
Selection Criterion
Akaike Information Criterion (AIC)
Sample size corrected AIC (AICc)
Bayesian Information Criterion (BIC)

Equation
2k + nln(RSS/n)
AIC + (2𝑘 2 + 2𝑘)/(𝑛 − 𝑘 − 1)
nln(RSS/n) + kln(n)

k is the number of parameters.
n is the number of data points.
RSS is the residual sum of squares: RSS = ∑𝑛𝑖=1(𝐼𝑜𝑏𝑠 − 𝐼𝑐𝑎𝑙𝑐 )2.
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5.3
5.3.1

Results
UDP-GlcNAc moiety model construction.
UDP-GlcNAc can be divided into four distinct moieties: glucose, ribose, acetyl,

and uracil, in which isotopes incorporate through a metabolic network from an isotope
labeling source. The expected (expert-derived) moiety model of 13C isotope incorporation
from 13C-labeled glucose to UDP-GlcNAc (see Figure 5.2 B) is built based on well-studied
human central metabolism pathways that converge in UDP-GlcNAc biosynthesis, which is
corroborated with NMR data[68]. This expert-derived model is labeled as 6_G1R1A1U3,
representing six optimizable parameters, one for the glucose moiety (G1), one for the ribose
moiety (R1), one for the acetyl moiety (A1), and 3 for the uracil moiety (U3), for each
moiety state equation representing the fractional

13C

incorporation for each moiety. For

example, the g6 state represents the incorporation of 13C6 into the glucose moiety, whereas
the g0 state represents no incorporation of 13C. Since both g0 and g6 must sum to 1, there
is only one parameter that needs to be optimized for this moiety state equation. The set of
isotopologue intensity equations are derived using the moiety model parameters and
Equation 1, as illustrated for the expert-derived model in Figure 5.2 B. Figure 5.2 C shows
an alternative hypothetical moiety model 7_G0R3A1U3_g3R2R3_g6r5_r4 along with the
isotopologue intensity equations generated from the model.
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𝐼𝑥,𝑐𝑎𝑙𝑐 = ∑ 𝑖𝑐𝑎 ; 𝐼𝐶𝑥 = {𝑖𝑐𝑣 |𝑖𝑠𝑜𝑡𝑜𝑝𝑒_𝑐𝑜𝑛𝑡𝑒𝑛𝑡(𝑖𝑐𝑣 ) = 𝑥} ; 𝑖𝑐𝑣 = ∏ 𝑚𝑜𝑖𝑒𝑡𝑦_𝑠𝑡𝑎𝑡𝑒𝑗,𝑣𝑗

(1)

𝑗

𝑖𝑐𝑎∈𝐼𝐶𝑥

We also manually crafted 40 hypothetical moiety models to capture isotope flow
from [U-13C]-glucose into each moiety. This set of models provides a mechanism for
testing how robustly the expert-derived model can be selected from all the other models.

Figure 5.2. Example complex metabolite UDP-GlcNAc and associated moiety models.
A) Major human metabolic pathways from glucose to the four moieties of UDP-GlcNAc.
B) The expert-derived moiety model based on known human central metabolism pathways
with corroborating NMR data. C) An alternative hypothetical moiety model with simple
perturbations of the original expert-derived model.
5.3.2

A simple comparison of two moiety models
Model optimization aims to minimize an objective function that compares

calculated isotopologues based on moiety state parameters from the model to the directly
observed, experimentally-derived isotopologues. Figure 5.3 A shows the comparison of
optimized model parameters between the expert-derived moiety model (6_G1R1A1U3)
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and the hypothetical moiety model (7_G0R3A1U3_g3r2r3_r4) for three time points of
isotopologue intensity data, i.e. three sets of isotopologue intensities. In these model
optimizations, the SAGA-optimize method and absolute difference objective function were
used and DS0, DS1, and DS2 correspond to the 34h, 48h, and 72h time points in the FTICR-MS UDP-GlcNAc dataset. We can easily tell that the relative intensity of the
corresponding model parameters between these two models are quite different, suggesting
that the moiety-specific 13C isotopic incorporation derived from the same MS isotopologue
profile varies from one model to another. Furthermore, experiment-derived and model
parameter-calculated isotopologue profiles are shown in Figure 5.3 B, illustrating how
much better the expert-derived model vs an inaccurate model is able to reflect the observed
data.
A

Comparison of optimized model parameters
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Figure 5.3. Optimized results for 6_G1R1A1U3 and 7_G0R3A1U3_g3r2r3_r4 models.
Each model optimization was conducted 100 times. A) Comparison of mean of optimized
model parameters with standard deviation. B-D) Reconstruction of the isotopologue
distribution of UDP-GlcNAc from model parameters. Observed isotopologue data was
compared with the mean of calculated isotoplogue data with standard deviation from the
optimized parameters for each model.
5.3.3

Effects of optimization method on model selection
The first question we were interested in was whether the optimization method could

affect the model selection results. As in the previous analysis, we used 3 time points from
the FT-ICR-MS dataset, the AICc criterion, and an absolute difference objective function
in the initial trial. The optimization for each model was conducted 100 times, and we used
the average of the 100 optimization results in the analysis (see Table 5.3). Most
optimization methods can select the expert-derived model except for ‘SLSQP’. What
interested us most was that the ‘SLSQP’ method failed in model selection with the lowest
loss value (value returned from objective function) and is generally considered to be the
fastest converging of the optimization methods we tested.
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We repeated the experiment with the ‘SLSQP’ method 10 times and found that
model selection fails when the loss value approaches 0.3, suggesting strong instability of
model selection at a critical point. Model optimization aims to minimize the objective
function, which is actually a non-linear inverse problem, and one inherited issue in solving
a non-linear inverse problem is overfitting (i.e. fitting to error in the data). Therefore, we
developed the hypothesis that over-optimization of model parameters can lead to failure in
model selection.
Table 5.3. Comparison of optimization methods in model selection.
Optimization method
Loss value
AICc
Selected model
SAGA
0.469
-401.760
Expert-derived model
SLSQP
0.320
-408.341
7_G2R1A1U3_g5
L-BFGS-B
0.763
-342.164
Expert-derived model
TNC
0.870
-327.344
Expert-derived model
Dataset: FT-ICR-MS (combined); Selection criterion: AICc; Objective function: Absolute difference.

5.3.4

Over-optimization leads to failure in model selection.
To test the above hypothesis, we first tried to increase the stop criterion of ‘SLSQP’

method to control over-optimization. The results are shown in Table 5.4. When
optimization stops earlier, the expert-derived model can be selected, which supports our
hypothesis.
The SAGA-optimize method is more flexible in controlling the degree of
optimization simply by adjusting the number of optimization steps. The more steps, the
lower the average loss value reached by the optimization. Next, we performed a set of
experiments using the SAGA-optimize method with increasing number of optimization
steps to further validate the hypothesis. The results are summarized in the Table 5.5. We
can see that the loss value decreases as optimization step increases. When the loss value
reaches a certain critical point, the expert-derived model cannot be selected, further
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supporting the hypothesis that over-optimization can lead to failure in model selection.
Furthermore, the selected model can change with increasing degrees of over-optimization.
Based on the above results, we conclude that it is not the optimization method but the
degree of optimization that affects model selection, which is explained by overfitting to
error in the data when solving a non-linear inverse problem. When optimization reaches a
certain critical point, successful model selection cannot be guaranteed. Therefore, proper
control of the degree of optimization is of great importance in model selection.
Table 5.4. Over optimization experiments with ‘SLSQP’ method.
Optimization
Loss value
AICc
Selected model
method
SLSQP
0.320
-408.341
7_G2R1A1U3_g5
SLSQP
0.514
-393.934
Expert-derived model

Stop
criterion
‘ftol': 1e-06
‘ftol': 1e-05

Dataset: FT-ICR-MS (combined); Selection criterion: AICc; Objective function: Absolute difference.

Table 5.5. Over optimization experiments with SAGA-optimize method.
Optimization steps
Loss value
AICc
Selected model
500
2.070
-219.488
Expert-derived model
1000
1.754
-235.728
Expert-derived model
2000
1.377
-260.654
Expert-derived model
5000
0.941
-305.651
Expert-derived model
10000
0.664
-375.192
Expert-derived model
25000
0.469
-401.760
Expert-derived model
50000
0.408
-414.737
Expert-derived model
75000
0.328
-418.228
7_G2R1A1U3_g5
100000
0.316
-424.924
7_G1R2A1U3_r4
Dataset: FT-ICR-MS (combined); Selection criterion: AICc; Objective function: Absolute difference.

5.3.5

Effects of selection criterion on model selection

Next, we investigated whether selection criterion could affect model selection. We
compared the model selection results generated by SAGA-optimize with different model
selection criteria (see Table 5.6). From these results, we can see that the rank of top models
is quite consistent across different selection criteria, suggesting that these model selection
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criteria have little effect on robust model selection, at least under this model selection
context. Since our previous experiments used AICc as the selection criterion, we will stick
with AICc in the following experiments.
Table 5.6. Comparison of mode rank based on different model selection criteria.
Models

AICc

rank

AIC

rank

BIC

rank

Expert-derived model

-401.7597

1

-421.3026

1

-385.5009

1

7_G1R1A2U3

-384.3075

2

-413.1825

2

-371.4139

2

7_G2R1A1U3_g5

-381.2868

3

-410.1618

3

-368.3932

3

7_G1R2A1U3_r3

-379.2657

4

-408.1407

4

-366.3720

4

7_G1R2A1U3_r4

-378.8969

5

-407.7719

5

-366.0033

5

7_G2R1A1U3_g4

-375.9538

6

-404.8288

6

-363.0601

6

6_G1R1A1U3_g5

-374.9694

7

-394.5122

10

-358.7105

8

6_G1R1A1U3_r4

-374.1820

8

-393.7249

11

-357.9231

9

7_G1R1A1U4

-373.4563

9

-402.3313

7

-360.5626

7

6_G1R1A1U3_u4

-370.0716

10

-389.6145

13

-353.8127

11

7_G2R1A1U3_g1

-367.8353

11

-396.7103

8

-354.9416

10

7_G2R1A1U3_g2

-360.1668

12

-389.0418

14

-347.2732

13

7_G1R1A1U3C1

-360.0296

13

-388.9046

15

-347.1360

14

7_G1R2A1U3_r1

-354.8814

14

-383.7564

16

-341.9878

16

8_G1R2A2U3_r3

-354.4480

15

-395.8273

9

-348.0917

12

8_G2R1A2U3_g4

-351.9886

16

-393.3679

12

-345.6323

15

6_G0R2A1U3_g3r2r3_g6r5

-345.1277

17

-364.6706

21

-328.8689

17

8_G2R1A2U3_g1

-334.2882

18

-375.6675

17

-327.9319

18

7_G2R1A1U3_g3

-332.9148

19

-361.7898

22

-320.0211

19

7_G1R2A1U3_r2

-332.3262

20

-361.2012

23

-319.4326

21

8_G1R2A2U3_r1

-325.9344

21

-367.3137

18

-319.5781

20

8_G1R1A2U3C1

-324.5196

22

-365.8989

19

-318.1633

22

8_G2R1A2U3_g5

-324.5004

23

-365.8797

20

-318.1441

23

7_G0R2A2U3_g3r2r3_g6r5

-324.0749

24

-352.9499

26

-311.1813

25

7_G1R2A1U3_g3r2r3

-324.0721

25

-352.9471

27

-311.1784

26

8_G2R1A2U3_g2

-318.5771

26

-359.9564

24

-312.2208

24

6_G1R1A1U3_a1

-318.2498

27

-337.7927

31

-301.9910

28

8_G1R2A2U3_r4

-317.3169

28

-358.6962

25

-310.9606

27

8_G2R1A2U3_g3

-302.7897

29

-344.1690

28

-296.4334

29

8_G1R2A2U3_g3r2r3_g6r5_g5

-297.7429

30

-339.1222

30

-291.3866

30

8_G1R2A2U3_r2r3

-295.0078

31

-336.3871

32

-288.6515

31
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8_G1R2A2U3_r2

-294.7900

32

-336.1693

33

-288.4337

32

8_G1R2A2U3_g3r2r3

-292.7867

33

-334.1660

34

-286.4304

33

9_G2R2A2U3_r2r3_g6r5_g3_g5

-281.8920

34

-340.0458

29

-286.3433

34

7_G0R3A1U3_g3r2r3_g6r5_g5r4

-279.0349

35

-307.9099

37

-266.1412

36

9_G2R2A2U3_r2r3_g4

-273.5807

36

-331.7345

35

-278.0320

35

9_G2R2A2U3_r2r3_g5

-254.4087

37

-312.5625

36

-258.8599

37

9_G2R2A2U3_r2r3_g3

-248.2277

38

-306.3815

38

-252.6789

38

9_G2R2A2U3_r2r3_g2

-242.9984

39

-301.1522

39

-247.4497

39

9_G2R2A2U3_r2r3_g1

-242.4110

40

-300.5648

40

-246.8623

40

7_G0R3A1U3_g3r2r3_g6r5_r4

-226.7271

41

-255.6021

41

-213.8334

41

Dataset: FT-ICR-MS (combined); Optimization method: SAGA-optimize (25000 steps); Objective function: Absolute difference.

5.3.6

Effects of selection criterion on model selection
Considering that the dominant type of error existing in metabolomics datasets may

vary from dataset to dataset, different forms of objective function may affect model
optimization and then influence the results of model selection. Here, we test the effects of
four objective functions in the context of model selection: absolute difference, absolute
difference of logs, square difference, and difference of AIC. To speed up optimization, we
first split the FT-ICR-MS dataset based on time point (34h, 48h, 72h) into separate model
optimizations executed on their own CPU core, and then combine the optimization results
for the model selection. This functionality is provided by the moiety_modeling package.
We set a series of experiments for each objective function with SAGA-optimize method.
The results are shown in Table 5.7 to Table 5.10. In comparing Table 5.7 to Table 5.5, the
number of optimizations per time point provides roughly the same degree of optimization
as three times the number of optimization steps used on a combined optimization.
From these tables, we can see that optimization with the absolute difference of logs
objective function is less likely to fail (> 250000 steps) in the model selection compared to
the other three objective functions (10000 - 20000 steps). One interpretation from these
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results is that the FT-ICR-MS dataset is dominated by proportional error instead of additive
error. However, the AICc produced with the absolute difference of logs is significantly
higher (less negative) than that produced by the other objective functions. Therefore, this
objective function may simply be hindering efficient optimization, especially if the dataset
is dominated by an error structure that is not as compatible with this objective function.
From this alternative viewpoint, additive error may actually dominate this dataset. We used
a graphical method to visualize errors in both FT-ICR-MS and LC-MS datasets (Figure 5.4
and 5.5). For the plots of FT-ICR-MS datasets, we used another dataset generated from the
same procedure, which included two replicates at 0, 3h, 6h, 11h, 24h, 34h, and 48h time
points. For two replicates with proportional error, a scatter plot of each replicate against
the other will show an increasing spread of values with increasing signal, and the logtransformed data will collapse into a line. Plot of two replicates with additive error can be
viewed as uniformly deviated from the line of identity, but once log-transformed will show
an increasing spread of values with decreasing signal. The original plots of raw data
indicate existence of proportional error in both FT-ICR-MS and LC-MS datasets (Figure
5.4 A and 5.5 A). However, the original plots of normalized data almost collapsed to a
straight line (Figure 5.4 C and 5.5 C), suggesting that normalization somehow removes the
proportional error in the raw data. In addition, from the log-transformed plots, we can see
that additive error does not exist in the normalized FT-ICR-MS datasets (Figure 5.4 D),
but does exist in the normalized LC-MS datasets (Figure 5.5 D). The replicate plots of all
time points (Figure 5.6 & 5.7) show similar tendency with selected optimized datasets.
Based on the above results, the absolute difference of logs objective function can hinder
efficient optimization in FT-ICR-MS datasets. We also compared four objective functions
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in the context of model selection with LC-MS datasets (Table 5.11-5.14). From these tables,
we can see that model selection fails earlier with absolute difference of logs objective
function compared to other objective functions, also suggesting that additive error may
dominate in the normalized LC-MS datasets. Based on the above results, the objective
function clearly affects model selection and the selection of certain objective functions for
model optimization is able to increase resistance to failure in model selection caused by
over-optimization; however, this is likely due to less efficient model optimization caused
by the selection of an objective function not appropriate for the type of error in the data.
Table 5.7. Model selection test with absolute difference objective function.
Optimization steps
Loss value
AICc
Selected model
500
1.045
-293.540
Expert-derived model
1000
0.819
-330.411
Expert-derived model
2000
0.651
-361.038
Expert-derived model
5000
0.459
-408.167
Expert-derived model
10000
0.392
-422.516
Expert-derived model
15000
0.359
-431.276
Expert-derived model
20000
0.290
-434.468
7_G1R1A2U3
25000
0.285
-436.909
7_G1R1A2U3
Dataset: FT-ICR-MS (split); Selection criterion: AICc; Objective function: absolute difference.

Table 5.8. Model selection test with square difference objective function.
Optimization steps
Loss value
AICc
Selected model
500
0.085
-298.516
Expert-derived model
1000
0.047
-330.096
Expert-derived model
2000
0.023
-367.279
Expert-derived model
5000
0.011
-404.509
Expert-derived model
10000
0.007
-425.695
Expert-derived model
15000
0.005
-429.869
7_G2R1A1U3_g5
20000
0.005
-435.348
7_G1R2A1U3_r4
Dataset: FT-ICR-MS (split); Selection criterion: AICc; Objective function: square difference.
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Table 5.9. Model selection test with absolute difference of logs objective function.
Optimization steps
Loss value
AICc
Selected model
500
31.647
-221.501
Expert-derived model
1000
29.628
-223.363
Expert-derived model
2000
28.164
-224.330
Expert-derived model
5000
27.096
-225.911
Expert-derived model
10000
26.631
-227.499
Expert-derived model
15000
26.469
-227.690
Expert-derived model
20000
26.398
-227.780
Expert-derived model
25000
26.271
-228.178
Expert-derived model
50000
26.126
-228.892
Expert-derived model
100000
25.949
-228.926
Expert-derived model
150000
25.865
-229.926
Expert-derived model
250000
25.777
-230.232
Expert-derived model
Dataset: FT-ICR-MS (split); Selection criterion: AICc; Objective function: absolute difference of logs.

Table 5.10. Model selection test with difference of AIC objective function.
Optimization steps
Loss value
Selected model
500
-345.559
Expert-derived model
1000
-371.852
Expert-derived model
2000
-398.570
Expert-derived model
5000
-436.582
Expert-derived model
10000
-458.064
7_G1R1A2U3
15000
-467.960
7_G2R1A1U3_g5
Dataset: FT-ICR-MS (split); Selection criterion: AICc; Objective function: difference of AIC.
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Figure 5.4. Error analysis in FT-ICR-MS datasets.
A and B are plots of raw data. C and D are plots of renormalized data after natural
abundance correction. All these plots contain 3 time points (12 – 36h).
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Figure 5.5. Error analysis in LC-MS datasets.
A and B are plots of raw data. C and D are plots of renormalized data after natural
abundance correction. All these plots contain 3 time points (12 – 36h).
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Figure 5.6. Error analysis in FT-ICR-MS datasets.
A and B are plots of raw data. C and D are plots of renormalized data after natural
abundance correction. All these plots contain all time points.
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Figure 5.7. Error analysis in LC-MS datasets.
A and B are plots of raw data. C and D are plots of renormalized data after natural
abundance correction. All these plots contain all time points.
Table 5.11. Model selection test with absolute difference objective function.
Optimization steps
Loss value
AICc
Selected model
500
0.840
-344.734
Expert-derived model
1000
0.682
-368.696
Expert-derived model
2000
0.580
-386.000
Expert-derived model
5000
0.492
-398.243
Expert-derived model
10000
0.447
-402.611
Expert-derived model
15000
0.430
-405.722
Expert-derived model
25000
0.458
-407.414
6_G1R1A1U3
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: absolute difference.
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Table 5.12. Model selection test with square difference objective function.
Optimization steps
Loss value
AICc
Selected model
500
0.031
-348.250
Expert-derived model
1000
0.021
-368.818
Expert-derived model
2000
0.015
-387.196
Expert-derived model
5000
0.011
-404.563
Expert-derived model
10000
0.010
-411.177
Expert-derived model
15000
0.010
-413.499
Expert-derived model
25000
0.009
-415.498
Expert-derived model
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: square difference.

Table 5.13. Model selection test with absolute difference of logs objective function.
Optimization steps
Loss value
AICc
Selected model
500
50.595
-315.616
Expert-derived model
1000
47.213
-319.026
Expert-derived model
2000
44.137
-323.619
Expert-derived model
5000
40.811
-320.949
Expert-derived model
10000
39.474
-328.551
Expert-derived model
15000
57.856
-331.700
6_G1R1A1U3
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: absolute difference of logs.

Table 5.14. Model selection test with difference of AIC objective function.
Optimization steps
Loss value
Selected model
500
-365.957
Expert-derived model
1000
-389.987
Expert-derived model
2000
-409.322
Expert-derived model
5000
-427.064
Expert-derived model
10000
-435.618
Expert-derived model
15000
-437.970
Expert-derived model
25000
-439.533
Expert-derived model
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: difference of AIC.

5.3.7

Effects of information quantity on model selection
From the above experiments, we found that over-optimization is a primary cause

for failure in model selection and this is affected by the objective function used. The next
question is whether the quantity of information affects model selection. One basic approach
is to utilize more datasets in order to overcome the effects of over-optimization. In the
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following experiments, we repeated single model optimization 10 times in order to
pragmatically finish these computational experiments. Every experiment was conducted
10 times using the AICc criterion and the absolute difference objective function. We used
the SAGA-optimize method to test where model selection starts to fail.
First, we used decreasing number of time points of the LC-MS dataset to test
whether data quantity affects model selection (Figure 5.8 A, Table 5.15). However, model
selection failed with few optimization steps when all five time points were included and
when only one time point was included, with the most robust model selection occurring
with 3 time points. Initially, these results were not expected, until we realized that the
relative isotopologue intensity of the 0 and 6h time points is concentrated within the 13C0
isotopologue with zero 13C tracer. Thus, these datasets are less informative with respect to
capturing the isotope flow from labeling source to each moiety in the metabolite. When the
0 and 6h time points are removed, the selection results improved significantly. Likewise,
when information-rich time points are removed, the model selection robustness decreases
as well. Similar results were obtained when testing the FT-ICR-MS dataset (Figure 5.8 B).
Taken together, the addition of information-rich data contributes to successful model
selection while the addition of information-poor data detracts from successful model
selection.
To further test this concept, we investigated whether combining FT-ICR-MS (34h, 48h,
72h) and LC-MS (12h, 24h, 36h) datasets can prevent failure in model selection (Figure
5.8 C). From the comparison, we can see that combining information-rich FT-ICR-MS and
LC-MS datasets is much more resistant to failure of model selection than just using the
information-rich FT-ICR-MS or LC-MS dataset, strongly supporting our previous
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conclusions that utilizing more information-rich datasets can prevent failure in model
selection. Similar results were obtained with absolute difference of logs objective function
(Figure 5.9). These datasets were collected at different times, on very different mass
spectrometry platforms. One used chromatographic separation while the other utilized
direct infusion. However, the really surprising part is that the datasets were derived from
different human cell cultures: LnCaP-LN3 human prostate cancer cells and human
umbilical vein endothelial cells.
A

B
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C

Figure 5.8. Comparison of the log optimization steps where model selection with different
datasets begins to fail.
A) Test with LC-MS datasets. LC-MS_1 to LC-MS_5 represent LC-MS datasets with 36h,
24-36h, 12-36h, 6-36h and 0-36h. B) Test with FT-ICR-MS datasets. FT-ICR-MS_1 to FTICR-MS_3 represent FT-ICR-MS datasets with 48h, 48-72h and 34-72h. C) Test with
combination of LC-MS (12h, 24h, 36h) and FT-ICR-MS (34h, 48h, 72h) datasets. The
median values are indicated in the plots.
Table 5.15. Inclusion of less informative dataset can lead to failure in model selection.
Optimization
steps

5 time points
(0-36h)

4 time points
(6-36h)

500

ED model

ED model

1000

ED model

2000

Selected model
3 time points
(12-36h)

2 time points
(24-36h)

1 time point
(36h)

ED model

ED model

ED model

ED model

ED model

ED model

ED model

ED model

ED model

ED model

ED model

ED model

5000

6_G1R1A1U3_u4

6_G1R1A1U3_u4

ED model

ED model

7_G1R2A1U3_r1

10000

6_G1R1A1U3_u4

6_G1R1A1U3_u4

ED model

7_G1R2A1U3_r1

7_G1R2A1U3_r1

15000

6_G1R1A1U3_u4

6_G1R1A1U3_u4

6_G1R1A1U3_u4

7_G1R2A1U3_r1

7_G1R2A1U3_r1

25000

6_G1R1A1U3_u4

6_G1R1A1U3_u4

6_G1R1A1U3_u4

7_G1R2A1U3_r1

7_G1R2A1U3_r1

Dataset: LC-MS (split); Objective function: log difference; Selection criterion: AICc; Optimization method: SAGA-optimize.
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Figure 5.9. Comparison of the log of optimization steps where model selection with
different datasets begins to fail with absolute difference of logs objective function.

5.4

Discussion
Here, we discussed the importance of model selection in isotopic flux analysis as a

proxy for metabolic flux analysis and factors that affect robust model selection. We found
that it is not the optimization method per se, but the degree of optimization that influences
model selection, due to the effects of over-optimization, i.e. fitting of model parameters
based on the error in the data. Overfitting is a known problem typically due to the illconditioning of the nonlinear inverse problem that is partially ill-posed. Moreover, the
objective function in model optimization is also of great importance in model selection.
Proper selection of an objective function can help increase resistance to failure in model
selection. This may mean that different objective functions should be used for model
selection versus parameter optimization for flux interpretation. Most SIRM experimental
datasets have few collected replicates and time points due to the cost and effort required to
acquire these datasets. The lack of replicates makes it impractical to directly estimate error
in many of these datasets. Also, the presence of different types of systematic error like ion
suppression can limit the overall effectiveness of replicate-based error analysis. With our
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moiety modeling framework, we are able to conduct a set of gradient experiments with
varying amounts of optimization (i.e, number of optimization steps) using the SAGAoptimize method to estimate the failure point in model selection caused by overfitting.
Furthermore, we found that incorporation of less informative datasets can hinder successful
model selection since they cannot properly represent the incorporation of isotopes
simulated by moiety models, which can lead to increased errors in model selection. On the
other hand, combination of informative datasets (i.e. time points with significant isotope
incorporation) can help control failure in model selection, which suggests that informative
datasets in public metabolomics repositories can be combined to facilitate robust model
selection. Moreover, these datasets do not need to come from identical biological systems,
just biological systems that utilize the same part of metabolism being measured and
modeled. The implication is that SIRM datasets in public repositories of reasonable quality
can be combined with newly acquired datasets to improve model selection. Furthermore,
curation efforts of public metabolomics repositories to maintain high data quality and
provide metrics of measurement error could have a huge impact on future metabolic
modeling efforts.
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CHAPTER 6. CONCLUSION
In this project, we worked on the development of computational methods and tools for
analyzing and interpreting metabolomics data derived from SIRM experiments. Despite
SIRM experiments which can generate enriched metabolic features containing isotopic
flow through cellular metabolism, the lack of corresponding analytic tools and methods
greatly hinders the characterization of metabolic phenotypes and their downstream
applications. Both detailed metabolic modeling and quantitative analysis methods are
required for better interpretation of the complex metabolomics data. Currently, there is no
relatively comprehensive metabolic network at an atom-resolved level that can be used for
deriving context-specific metabolic models for a given metabolic profile. In addition, most
existing software packages conduct metabolic flux analysis based on a predefined
metabolic model, where novel metabolic mechanism can hardly be detected. Besides, a
well-defined metabolic model is hard to achieve for complex biological system given the
limitations in our knowledge. Here, we developed a set of methods and tools to help address
those problems.
In Chapter 2, we developed a graph coloring method that creates unique identifiers for
unique atom as well as same identifier for symmetric atoms in a compound. Therefore,
additional cross-reaction atom mappings caused by symmetric atoms can be captured,
contributing to the construction of a more complete atom-resolved metabolic network. In
addition, the ordered compound coloring identifiers derived from the corresponding atom
coloring identifiers facilitate compound harmonization across metabolic databases, which
is an essential first step in cross-database network integration. While harmonizing
compounds between KEGG and MetaCyc, the graph coloring method also detected various
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issues and errors in both databases, suggesting that this method can also be used for
curating current metabolic databases. More importantly, the graph coloring method and
compound harmonization approach can be used to integrate any metabolic database that
provides a molfile representation of compounds, which will greatly facilitate future
expansion.
In addition to harmonizing compounds with specified atomic compositions, we
further integrated compounds with R group(s) via an optimized common subgraph
isomorphism algorithm in Chapter 3. We also addressed the issue of inconsistent atomistic
characteristics across databases by defining a set of relationships between compounds.
Meanwhile, the hierarchical relationships between metabolic reactions were created in
accordance with the classification of compound pairs. This hierarchical framework for
relating compounds and reactions can be an essential step to creating a comprehensive
organization of all reaction descriptions at a desired chemical specificity to fit a given
application. Such a comprehensive organization of reaction descriptions would be useful
to a wide range of possible applications, including metabolic modeling, metabolite and
reaction prediction, and network incorporation of newly discovered metabolites.
In addition, we made use of the atom identifiers derived from the neighborhoodspecific graph coloring method to evaluate the consistency of atom mappings across
harmonized reactions. Through the evaluation, we figured out that the documentation of
atom mappings in either database can contain issues. Compared to other representations,
KEGG RCLASS provides a concise RDM description of reaction atom mappings between
a reaction-product compound pair, which appears more resistant to consistency errors. This
resistance to consistency error is due to a separation of the atom mappings from the specific
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atom order in the molfile representations, which allows update molfile representations
without affecting the RDM descriptions. However, a few KEGG RCLASS entries are
computationally hard to parse due to a combinatorial issue caused by the several factors:
multiple reaction centers in a single reaction, symmetric compounds, and reaction
descriptions involving multi-steps. This combination of factors introduces a large number
of possibilities when match reaction center atoms to the RDM descriptions. To prevent this
combinatorial problem, one possible solution is to represent multiple reaction center atoms
with their match atoms and associated difference atoms within a paired substructure
representation, like sdfile.
The above work helps to build a comprehensive atom-resolved metabolic network.
However, this is just the first step in interpreting metabolomics datasets. In Chapter 4, we
presented a moiety modeling framework for deconvoluting metabolite isotopologue
profiles using moiety models along with the analysis and selection of the best moiety
model(s) based on the experimental data. This moiety modeling framework successfully
integrates model representation, model optimization, and model selection together. To our
knowledge, this is the first framework that can analyze datasets involving single and
multiple isotope tracers as demonstrated on simulated datasets for multiple tracer models
and both simulated and experimental datasets on single tracer models. Furthermore, rather
than a single predefined metabolic model, this method allows comparison of multiple
metabolic models derived from a given metabolic profile. In addition, we demonstrated the
robust performance of the moiety modeling framework in model selection on real
experimental datasets with a 13C-labeled UDP-GlcNAc isotopologue dataset. The selection
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of correct moiety models is the premise for generating deconvolution results that can be
accurately interpreted in terms of relative metabolic flux.
In Chapter 5, we further explored the data quality requirements and the factors that
affect model selection. We have demonstrated the importance of model selection in
isotopic flux analysis as a proxy for metabolic flux analysis. Here, we found that it is not
the optimization method per se, but the degree of optimization that influences model
selection, due to the effects of overfitting. Moreover, the objective function in model
optimization also plays important role in model selection. Our results indicated that proper
selection of an objective function can help increase resistance to failure in model selection,
which suggests that different objective functions should be used for model selection versus
parameter optimization for flux interpretation. It is often difficult to acquire SIRM
experimental datasets with enough replicates at multiple time points due to the cost and
effort, making it impractical to directly estimate error in these datasets. In addition,
different types of systematic error can limit the effective replicate-based error analysis. To
address this problem, we can conduct a set of gradient experiments with varying
optimization degree using the SAGA-optimize method to estimate the failure point in
model selection caused by overfitting. We also found that incorporation of less informative
datasets can hinder successful model selection since they lack enough information
representing the incorporation of isotopes simulated by moiety models, leading to
increased errors in model selection. On the other hand, combination of informative datasets
can help control failure in model selection, suggesting that informative datasets in public
metabolomics repositories can be combined to facilitate robust model selection. More
importantly, these datasets do not need to come from the same biological systems. We just
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need to make sure that the biological systems utilize the same part of metabolism being
measured and modeled. The implies that SIRM datasets in public repositories of reasonable
quality can be combined with newly acquired datasets to improve model selection.
Therefore, curation efforts of public metabolomics repositories to maintain high-quality
data and provide metrics of measurement error could have a huge impact on future
metabolic modeling.
In conclusion, compound and reaction harmonization through the neighborhoodspecific coloring method can help build a more comprehensive metabolic network, which
will help derive the proper context-specific metabolic models for metabolic flux analysis.
The moiety model modeling framework has demonstrated its robust performance in
isotopologue deconvolution and moiety model selection. We also devised a strategy to deal
with failure in model selection caused by over-optimization.

132

APPENDICES
APPENDIX 1. SOFTWARE
moiety_modeling software:
GitHub - https://github.com/MoseleyBioinformaticsLab/moiety_modeling
PyPI - https://pypi.org/project/moiety-modeling/
SAGA-optimization package:
GitHub - https://github.com/MoseleyBioinformaticsLab/SAGA_optimize
PyPI - https://pypi.org/project/SAGA-optimize/

APPENDIX 2. DATA AVAILABILITY
Atom Identifiers Generated by a Neighborhood-Specific Graph Coloring Method Enable
Compound Harmonization across Metabolic Databases:
https://doi.org/10.6084/m9.figshare.12894008.
Hierarchical Harmonization of Atom-Resolved Metabolic Reactions across Metabolic
Databases: https://doi.org/10.6084/m9.figshare.14703999.
Moiety Modeling Framework for Deriving Moiety Abundances from Mass Spectrometry
Measured Isotopologues:
https://figshare.com/articles/moiety_modeling_framework/7886135.
Robust Moiety Model Selection Using Mass Spectrometry Measured Isotopologues:
https://figshare.com/articles/moiety_model_selection/10279688.
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